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 Abbreviations 
 ACh             Acetylcholine 
 AP-1   Activating protein-1 
 AH                    Afterhyperpolarization 
 BAPTA                      1,2-bis(o-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid 
 BSA             Bovine serum albumin  
 [Ca2+]i                        Cytosolic free Ca2+ concentration  
 cAMP                        Cyclic adenosine 3',5'-monophosphate 
 CCH                          Carbachol  
 cDNA                       Complementary deoxyribonucleic acid 
 cGMP                       Cyclic guanosine 3',5'- monophosphate  
 CNS                          Central nervous system 
 CPA                          Cyclopiazonic acid  
 DAPI                         4´,6-Diamidino-2-phenylindol dilactate 
 DEPC-water         Diethylpyrocarbonat-Aqua dest. 
 DHP                          Dihydropyridine  
 DMEM                     Dulbecco´s modified Eagle´s Medium 
 DMSO                      Dimethylsulfoxide 
 dNTPs                       Deoxynucleotide triphosphates 
 EGTA                        Ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’- 
                                    tetraacetic acid 
 eNOS                        Endothelial nitric oxide synthase 
 ENS                          Enteric nervous system 
 EPSPs                      Excitatory postsynaptic potentials 
 ER                            Endoplasmic reticulum  
 FCS                          Fetal calf serum 
 Fura-2/AM              Fura-2-acetoxymethylester 
 GAPDH                   Glycerinaldehyde-3-phosphate-dehydrogenase 
 GFAP                      Glial fibrillary acidic protein  
 GI                            Gastrointestinal tract  
 HEPES                   N-(2-hydroxyethyl)-piperazine-N´-(2-ethanol sulfonic acid)  
 ICC                         Interstitial cells of Cajal  
 IgG                         Immunoglobuline 
 IGLE                      Intraganglionic laminar endings  
 IL-1β                     Interleukin-1β 
 IMAs                      Intramuscular arrays 
 iNOS                     Inducible nitric oxide synthase 
 IP3                         Inositol 1,4,5-trisphosphate  
 IPANs                   Intrinsic primary afferent neurons  
 IPSPs                    Inhibitory post-synaptic potentials 
 IP3R                       Inositol trisphosphate receptor 
 mRNA                  Messenger ribonucleic acid 
 NADPH                Nicotinamide adenine dinucleotide phosphate 
 NANC                   Non-adrenergic non-cholinergic 
 IV
 
NF-κB                   Nuclear factor κB  
NO                          Nitric oxide 
NOS                      Nitric oxide synthase 
nNOS                    Neuronal nitric oxide synthase 
O2–                        Superoxide anions 
ONOO¯                  Peroxynitrite anion  
PAA                       Phenylalkylamine 
PB                          Phosphate buffer 
PBS                        Phosphate-buffered saline 
PBS-T                    Triton-X-containing phoshate-buffered saline  
PFA                        Paraformaldehyde 
PGP 9.5                 Protein gene product 9.5 
ROS                        Reactive oxygene species 
rpm                          Rotations per minute 
RT-PCR                  Reverse transcriptase-Polymerase chain reaction 
RYR                        Ryanodine receptor 
SEM                        Standard error of the mean 
SERCA                   Sarcoplasmic-endoplasmic reticulum Ca2+ATPase 
SNP                        Sodium nitroprusside 
TAE                        Tris-acetate/EDTA buffer 
TNF-α                    Tumor necrosis factor-α 
TNFR                      Tumor necrosis factor receptor 
VDCCs                  Voltage-dependent Ca2+ channels 
VOCCs                  Voltage-operated Ca2+ channels 
V/V                          Volume per Volume 
W/V                         Weight per Volume 
λ                               Wave length 
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1. Introduction 
 
1.1. The myenteric plexus in the small intestine 
The myenteric (Auerbach's) plexus is the outer of the two major 
plexuses of the enteric nervous system (ENS), which lies within the 
intestinal wall controlling several functions of the gastrointestinal tract 
(Costa et al. 2000, Figure 1). 
The myenteric plexus is located between the longitudinal and the 
circular layers of the smooth muscle that form the gut’s muscularis 
externa and regulates the motility (Gershon 1981). The plexus 
continues around and along the gut wall and has a connection with the 
other part of the enteric nervous system, i.e. the submucous plexus, 
which controls the transport of water and electrolytes across the 
intestinal epithelium (Furness and Costa 1987). 
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Figure 1.1: Schematic drawing of the enteric nervous system. Modified after 
Furness and Costa (1987). 
 
Ultrastructure of enteric ganglia 
The myenteric plexus consists of a network of nerve strands and small 
ganglia. The enteric ganglia, unlike other autonomic ganglia, do not 
contain blood vessels, connective tissue cells, or collagen fibers. The 
absence of connective tissue and the close packing of neurons and glia 
gives an appearance similar to the central nervous system. The ganglia 
are not encapsulated, but lie in the connective tissue between the 
muscle layers (Furness and Costa 1987). 
The cells of the ganglia receive nutrients by diffusion from the blood 
vessels within the discontinuous basal lamina surrounding the ganglia. 
The neurons and their axons in the ganglion are partly surrounded by 
glial cells. The glial cells, which are histologically characterized by 
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gliofilaments, divide the neurites in the nerve strands to bundles 
(Gershon 1981). 
 
1.2. Classification of myenteric neurons 
Two types of myenteric neurons have been determined using the 
intracellular recording technique with microelectrodes. S/type1 cells 
have prominent fast excitatory postsynaptic potentials (fast EPSPs) and 
their action potentials are generated by the classic mechanism of 
activation and inactivation of time- and voltage-dependent Na+ and K+ 
channels (North 1982). The other type of myenteric neurons was termed 
AH/type2 cells, which do not show fast EPSPs. The action potential of 
these cells, at least at their soma, is carried by a Ca2+ current. This 
action potential is followed by a prolonged afterhyperpolarization (AH) 
generated by an outward Ca2+-activated K+ current, which lasts for up to 
30 s (Nishi and North 1973, Hirst et al. 1974). 
Morphologically, the ganglion cells in the myenteric plexus have been 
divided by the neuroanatomist Dogiel. Dogiel (1899) described type I 
cells as flattened cells with short dendrites and one axon. Type II cells 
possess an angular shape with many ramified dendrites. Type III cells 
are similar to the type II, but have more and shorter processes (Costa et 
al. 1986).  
The electrophysiological identification of cells as the AH type was 
almost always corrrelated with a Dogiel type ΙΙ morphology, whereas 
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cells electrophysiologically defined as S cells had in most cases a type Ι 
morphology (Bornstein et al. 1984). However, there are other neurons in 
the myenteric plexus, whose shape and electrophysiologic behavior do 
not fit to the previous classification (Wood 1994). 
The functional classes of myenteric neurons are the intrinsic primary 
afferent neurons (IPANs), interneurons and motor neurons (Wood 
1994). The IPANs respond to luminal chemical stimuli, to mechanical 
deformation of the mucosa and to stretch or tension of the muscle. This 
suggests the presence of processes of these cells into the mucosa 
(Hendriks et al. 1990, Costa et al. 2000). Intracellular microelectrode 
studies suggest that intrinsic primary afferent neurons are AH/Dogiel 
type ΙΙ neurons (Kunze et al. 1998). 
The interneurons represent the connection between the sensory and the 
motor neurons and form the information-processing circuitry of the 
myenteric plexus (Wood 1994). Interneurons have Dogiel type Ι (Kunze 
et al. 1998) and Dogiel type ΙΙ morphology (Wood 1994). The motor 
neurons having Dogiel type Ι morphology represent the final motor 
output to the intestinal muscle. Both excitatory and inhibitory motor 
neurons are found in the myenteric plexus, which release 
neurotransmitters that cause contraction and inhibition of the contractile 
activity of the intestinal muscle, respectively (Wood 1994, Costa et al. 
2000). 
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1.3. Synaptic events in myenteric neurons  
The principal events found in the myenteric cells are fast excitatory 
postsynaptic potentials, slow excitatory postsynaptic potentials, slow 
inhibitory postsynaptic potentials and presynaptic inhibition of 
transmission from excitatory synapses (Furness and Costa 1987). 
 
Fast excitatory postsynaptic potentials 
Fast EPSPs are depolarizations of the membrane lasting less than 50 
ms. They are found in S/type1 neurons and are rare in AH/type2 
neurons (Wood 1984). Receptors directly coupled to nonspecific cation 
channels are involved in the mechanism of fast EPSPs (Derkach et al. 
1989). The putative neurotransmitters involved in fast EPSPs are 
reported to be acetylcholine (ACh) and serotonin (5-HT) via 5-HT3 
receptors. 
 
Slow excitatory postsynaptic potentials 
Prolonged depolarizations lasting for 5–20 s were shown in both S and 
AH neurons of the myenteric plexus (Katayama and North 1978). They 
are most pronounced in AH/type2 neurons, leading to a phase of 
hyperexcitability (Wood 1994). The slow EPSPs are associated with a 
reduction in membrane permeability to potassium ions (Wood and 
Mayer 1979), due to block of the Ca2+ channels by the neurotransmitter, 
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a reduction of the intraneural Ca2+ concentration and/or a closure of 
Ca2+-activated K+ channels (Grafe et al. 1979). Experimental evidence 
suggested that cyclic AMP is involved in slow EPSPs of AH/type2 
myenteric neurons (Nemeth et al. 1984). The putative neurotransmitters 
responsible for slow EPSPs are listed in Table 1.1.  
 
Slow inhibitory postsynaptic potentials 
Slow IPSPs are observed in a small proportion of myenteric neurons 
lasting for 2-40 s and are associated with an increase in potassium 
conductance (Johnson et al. 1980). Available evidence suggests that 
GTP-binding proteins are involved in direct coupling of the receptors to 
the potassium channels (Surprenant and North 1988). Norepinephrine is 
the putative neurotransmitter responsible for the slow IPSPs (Johnson 
et al. 1980). The functional significance of slow IPSPs is believed to be 
the termination of the excitatory state of slow synaptic excitation and 
reestablishment of the low excitability state in the ganglion cell soma 
(Wood 1994). 
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Presynaptic inhibition 
The presynaptic inhibition is a mechanism that suppresses the release 
of neurotransmitters by an action of chemical messengers at receptors 
on the axons. It is found at both fast and slow excitatory and inhibitory 
synapses as well as at neuroeffector junctions (Schemann and Wood 
1989). It functions to regulate the concentration of neurotransmitter 
within the synaptic or junctional space (Wood 1994). 
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Table 1.1. Some messenger substances found in myenteric neurons, 
enteroendocrine cells and immune cells of the gut. 
 
Slow excitatory 
postsynaptic potentials 
Slow inhibitory post-
synaptic potentials 
 
Presynaptic 
inhibition 
 
Acetylcholine Acetylcholine Dopamine 
Serotonin (5-HT) Serotonin (5-HT) Norepinephrine 
Substance P  Enkephaline Histamine 
Histamin Neurotensin Serotonin (5-HT) 
Vasoactive Intestinal 
Peptide(VIP) 
Cholecystokinin Opioid peptides 
Cholecystokinin Somatostatin Acetylcholine 
Gastrin-releasing peptide Purines Peptide YY 
Bombesin Galanine Adenosine 
Caerulein Neuropeptide Y Neuropeptide Y 
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1.4. The communication between the ENS and the central nervous 
system 
The concept of autonomy of the ENS 
The enteric nervous system of the gastrointestinal (GI) tract has 
traditionally been viewed as a system of ganglia that operates largely 
independently of the brain and the spinal cord. Because of this 
postulated autonomy, the ENS has even been characterised as the 
“little brain” in the gut. Recent neural tracing studies, however, 
challenge this canon of ENS autonomy (Powley 2000). 
The prevailing view concerning vagal projections to the GI tract was 
established by Langley (Holst et al. 1997). Langley (1922) recognized 
the disparity between the few thousand preganglionic axons of the 
vagus and the millions of enteric neurons. Therefore, he hypothesized 
that vagal preganglionic neurons project to a few specialized 
postganglionic “vagal neurons” or “mother cells”, which, in turn, project 
divergently within the plexuses to coordinate autonomic control of the 
gut. This concept was reinforced by Bayliss and Starling's (1899) 
observation of organized propulsion of intraluminal boluses in intestinal 
segments removed from the body and studied in vitro (Langley and 
Magnus 1905). More recently, in a similar argument, Wood (1987) 
proposed that vagal parasympathetic preganglionic neurons project to 
selected “command neurons” located within the ENS (Holst et al. 1997). 
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Langley (1922) divided the autonomic nervous system into three 
divisions, an enteric, a sympathetic and a parasympathetic division.The 
enteric nervous system was classified as a separate autonomic entity 
because the bulk of enteric neurons were likely to receive no direct input 
from the central nervous system and could be accommodated in neither 
the sympathetic nor the parasympathetic definitions (Kirchgessner and 
Gershon 1989). Although the command neuron hypothesis has found 
wide acceptance, the supporting evidence for the concept is largely 
indirect and based primarily on the discrepancy between the number of 
preganglionic neurons or their axons and the number of enteric neurons 
to be innervated (Holst et al. 1997).  
 
Recent neural tracing studies challenge this idea of complete ENS 
autonomy. Advances in neural tracing technologies have it made 
possible to collect structural observations that directly address the 
extent of the interconnections between the enteric and the central 
nervous system (Powley 2000). The observation of Kirchgessner and 
Gershon (1989) was consistent with the mother cell/command neuron 
concept, however, they stated: “despite the ability of the ENS to function 
independently of control by the CNS, it does not normally do so. The 
CNS affects the motility and secretory activity of the bowel” and refered 
to previous literature (Kerr and Preshaw 1969, Gonella et al. 1987, 
Roman and Gonella 1987). Other tracer and electrophysiological 
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experiments have revealed dense networks of preganglionic endings 
within ganglia with varicosities contacting large numbers of myenteric 
neurons (Berthoud et al. 1990, Schemann and Grundy 1992, Powley et 
al. 1994, Berthoud et al. 1995, Wang and Powley 2000). 
 
1.5. Vagal input to the enteric nervous system of the small 
intestine 
How do vagal fibers interact with intrinsic neurons to influence the 
output of effectors in the gut? 
The vagus nerve supplies the majority of the visceral afferents that allow 
the central nervous system to coordinate the functions of the gut (Fox et 
al. 2000). Prechtl and Powley (1990) have demonstrated that 70 – 80 % 
of the fibers in the abdominal vagus are sensory. The vagus nerve 
contains both sensory and motor axons that have been implicated in the 
control of gastrointestinal physiology and ingestive behavior (Phillips et 
al. 1997). The vagal afferents are classified as mechanoreceptors and 
chemoreceptors (Grundy and Scratcherd 1989). Three types of vagal 
mechanoreceptors have been identified on the basis of their location, 
morphology and electrophysiologic properties (Powley and Phillips 
2002). One of them are the intraganglionic laminar endings (IGLE), 
which lie parallel to the muscle layers and interact with both neural and 
connective tissue elements around myenteric ganglia (Nonidez 1946, 
Rodrigo et al. 1975). IGLEs are well organized to detect contraction-
 12
related tension and other distortion for purpose of coordinating the 
rhythmic motor patterns of the gut such as peristalsis (Fox et al. 2000). 
The second type of vagal afferents found in the smooth muscle of the 
intestine are the intramuscular arrays (IMAs) located within the circular 
and longitudinal muscle sheets. They run parallel to the smooth muscle 
fibers of the muscular sheet and form appositions with interstitial cells of 
Cajal (Berthoud and Powley 1992, Wang and Powley 1994). On the 
basis of their morphology and distribution within the muscle wall, IMAs 
appear to be specialized to operate as stretch receptors that are 
capable of transducing changes in the length of their respective muscle 
sheets (Wang and Powley 2000). IGLEs are widley distributed in the 
initial segment of the duodenum. Their density is reduced in the distal 
small intestine. The third type of vagal mechanoreceptors has been 
identified electrophysiologically and is postulated to act as mucosal 
mechanoreceptors (Powley and Phillips 2002). 
 
Vagal chemoreceptors are distributed in the lamina propria. They are 
situated among the intestinal crypts, they enter and ramify in individual 
villi of the mucosa and end near the basal side of the epithelial cells 
(Berthoud et al. 1995). The chemoreceptors are sensitive to all three 
macronutrients and to changes in pH and osmolarity within the intestinal 
lumen (Mei 1985, Ritter et al. 1992). Mucosal terminals are abundant in 
the proximal duodenum, becoming relatively sparse in the distal small 
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intestine (Williams et al. 1997). The extensive distribution of vagal 
afferents in this region points to the importance of the proximal 
duodenum in the detection of nutrients, distension and hormones and 
thus the important role in the feedback control of gastric activity as well 
as feeding behavior (Hölzer and Raybould 1992, Smith et al. 1994, 
Walls et al. 1995). 
 
1.6. Modulation of the enteric nervous system by the central 
nervous system 
The digestive tract is endowed with an enteric nervous system capable 
of integrating a substantial volume of local neural, hormonal and 
immune afferent signal data (Wood 1984). Nevertheless, this enteric 
neural network acts principally as a local controller of digestive organ 
functions subject to descending neural control from the CNS (Wood 
1987). Vago-vagal reflexes, and the factors that modulate their 
functions, represent the next hierarchy in the coordinated neural control 
of the entire digestive tract (Powley et al. 1994). 
The exact role of both CNS and ENS in the control of GI tract motility 
used to be a matter of controversy. Some investigators have defined the 
peristalsis reflex as a local reflex with intrinsic afferent neurons in the 
myenteric plexus independent of the extrinsic nerve supply to the GI 
tract (Wood 1984). Others have implied a role of the vagal afferents in 
the reflex (Powley 2000). However, Grider and Jin (1994) indicated that 
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sensory neurons activated by mucosal stimulation are wholly intrinsic, 
whereas sensory neurons activated by muscle stretch are extrinsic with 
cell bodies in the CNS. 
How the vagal fibers interact with intrinsic neurons to influence the 
output of effectors in the gut has not yet been demonstrated 
(Kirchgessner and Gershon 1989), however, some investigators have 
reported the presence of CGRP (calcitonin-gene related peptide) and 
substance P in the axons of the vagal afferents which synapse with the 
myenteric neurons (Berthoud and Neuhuber 2000, Powley 2000). At the 
level of the efferent fibers, subsets of myenteric neurons containing 5-
HT and VIP have been described (Kirchgessner and Gershon 1989). 
 
1.7. Sympathetic influence on gastrointestinal function 
The primary adrenergic innervation of the small intestine is located at 
the myenteric plexus. The sympathetic innervation of the smooth 
musculature is relatively sparse suggesting that the adrenergic inhibiting 
mechanism takes place primarily at the myenteric ganglia (Jacobowitz 
1965). 
The adrenergic inhibition of the intestinal motility is by acting on the 
excitatory pathway through the enteric cholinergic neurons (Jansson 
and Martinson 1966) and/or on the extrinsic excitatory parasympathetic 
nervous activity (Lundgren 2000). Pharmacological studies have shown 
that noradrenergic nerve fibers cause a presynaptic inhibition of 
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acetylcholine release from enteric excitatory motor cholinergic neurons 
mediated through α-receptors (Drew 1978). 
The noradrenergic nerves innervating the intestine usually are inactive 
in the resting individual. Their discharge is evoked through reflex 
pathways originating both out- or inside the gastrointestinal tract 
(Furness and Costa 1987). The intestino-intestinal reflexes which are 
evoked by distension or mucosal irritation of one part of the intestine 
can inhibit the movement of other areas involving spinal and 
prevertebral pathways (Kuntz and Saccomanno 1944). Pilipenko (1956) 
found that the intestinofugal fibers that arise from the myenteric nerve 
cells are involved in the peripheral intestino-intestinal inhibitory reflex 
evoked by noxious stimuli. For example rough handling of the viscera 
inhibits the motor activity of the intestine through the action of 
noradrenergic nerves to inhibit the activity of the enteric neurons 
(Furness and Costa 1987). The sympathetic pathway to the intestine 
encodes information above supraphysiological levels of intestinal 
pressure and forms the main pathway for mediating pain perception 
(Grundy 2002). 
Overall, the intestinal motor activity is controlled by the enteric nervous 
system, which itself is influenced by extrinsic nerves. The importance of 
the ENS in motor functions is illustrated by the obstruction when a 
segment of bowel is congenitally deprived of ganglion cells, as occurs in 
Hirschsprung´s disease (Bodian et al. 1949) and the motor dysfunction 
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after small bowel transplantation reflects the importance of the extrinsic 
innervation to the gut (Nakao et al. 1998). 
 
1.8. Nitric oxide 
Nitric oxide (NO) is an inorganic gaseous molecule that acts as an 
inhibitory neurotransmitter in the enteric nervous system. NO has been 
identified to be identical to the endothelium-derived relaxing factor 
discovered by Furchgott and Zawadzki (Palmer et al. 1987). This gas 
plays an important role in the non-adrenergic and non-cholinergic 
(NANC) neurotransmission in the intestine (Calignano et al. 1992) and it 
has been shown to act as an inhibitory neurotransmitter of interneurons 
(Wiklund et al. 1993) as well as of motor neurons innervating the 
intestinal muscle (Sanders and Ward 1992). NO has been determined 
to be involved in the descending inhibitory component of the peristaltic 
reflex in the GI tract (Costa et al. 1991). Nitric oxide is produced by the 
enzyme nitric oxide synthase (NOS), which catalyzes the conversion of 
L-arginine to L-citrulline and NO (Moncada et al. 1991). The mechanism 
by which NO is synthesized is NADPH- and Ca2+/calmodulin-dependent 
(Palmer and Moncada 1989, Busse and Mulsch 1990). 
Three isoforms of NOS have been detected (Dawson et al. 1991), the 
neuronal (n)NOS (NOS-1) and the endothelial (e)NOS (NOS-3) are 
constitutively expressed and are Ca2+-dependent, while the inducible 
(i)NOS (NOS-2) is Ca2+-independent. The neuronal and endothelial 
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isoforms occur under physiological conditions, whereas the inducible 
isoform is expressed e.g. in macrophages after activation by endotoxins 
and cytokines (Cattel and Janson 1995). However, iNOS activity has 
been reported in the gastrointestinal tract both under physiological as 
well under pathological conditions (Mancinelli et al. 2001). Besides 
enteric neurons, the interstitial cells of Cajal (ICC) and the smooth 
muscle cells seem to be able to express nNOS (Daniel et al. 2000, 
Wang et al. 2000). 
Due to its gaseous nature, NO does not need a classical release 
machinery, but is synthesized on demand and can easily diffuse from 
the producing cells into the target effector cells (Garthwaite et al. 1988). 
However, some evidences suggest that NO can be stored in form of 
nitrosothiols after binding at thiol containing amino acids (Thornbury et 
al. 1991). 
Nitric oxide exerts its action via activation of soluble guanylate cyclase 
and subsequent elevation of the second messenger guanosine 3',5'-
cyclic monophosphate (cGMP; Arnold et al. 1977), however, there have 
been reports of NO actions that are non-cGMP dependent (Garg and 
Hassid 1991). 
NO binds to iron in a heme moiety that is attached to guanylate cyclase 
and activates the enzyme. The consequence is a production of cGMP 
and the activation of a cGMP-dependent protein kinase, which may e.g. 
activate Ca2+-activated K+ channels responsible for the inhibitory 
 18
junction potential and relaxation of the intestinal muscle (Lang et al. 
2000), or may decrease the Ca2+ sensitivity of the contractile apparatus 
(Thornbury et al. 1991). 
Furthermore, NO has been identified to modify cellular proteins by S-
nitrosylation. The coupling of NO to the thiol side chain of cysteins to 
form an S-nitrosothiol seems to be an important mechanism for post-
translational regulation of most or all main classes of proteins (Hess et 
al. 2005). In addition, formation of peroxynitrite anion (ONOO-) through 
reaction of NO with superoxide (O2-) is implicated in NO-mediated 
cytotoxicity and may be involved in NO mediated immune responses by 
macrophages under pathological conditions (Beckman and Koppenol 
1996). 
NO has been found to have a role as presynaptic inhibitory modulator 
on acetylcholine and on substance P release from myenteric neurons of 
the guinea-pig small intestine (Wiklund et al. 1993, Kilbinger and Wolf 
1994). 
 
1.9. Interstitial cells of Cajal and NO 
Intestinal muscle possesses a mechanism for the self-generation of 
rhythmic changes in excitability (periodic depolarizations). The 
movement of the intestine depends on the superimposition of the action 
of nerves and hormones on this underlying rhythm, which are referred to 
as slow waves. They last from 2 to 5 s, have a variable amplitude (up to 
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20 mV), and occur at frequencies from 3 to 30 per min depending on the 
species and the region of gastrointestinal tract (Furness and Costa 
1987). 
The interstitial cells of Cajal (ICs) are the initiators of slow waves in the 
gastrointestinal tract (Thuneberg 1982). In addition to the role of ICs in 
generation of pacemaking, they serve as the mediator of certain forms 
of enteric motor neurotransmission (Sanders 1996). 
Interstitial cells have been found at the level of myenteric plexus (IC-
MP), in the muscle layers (IC-CM; IC-LM) and in the deep muscular 
plexus (IC-DMP) (Jiménez et al. 1999) forming synapse-like contacts 
with myenteric neurons (Ward 2000). IC-MP are thought to be involved 
in the generation of slow waves. IC-IMs and IC-DMP probably serve as 
mediators of neurotransmission (Horiguchi et al. 2003). Smith et al. 
(1989) reported that the inhibitory innervation of the gastrointestinal 
muscle is concentrated in regions, where ICs are located, and isolated 
ICs have been shown to be responsive to NO by changes in cellular 
levels of cGMP (Young et al. 1993). Furthermore, fibers of enteric 
neurons with NOS immunoreactivity that are closely associated with the 
cell bodies of ICs have been determined (Ward 2000). 
Impairment of ICs-mediated control of electrical events and 
neuromodulation has been implicated in several motility disorders such 
as grass sickness in horses and Crohn’s disease in human (Ward et al. 
1994, Altdorfer et al. 2002). Increased NOS immunoreactivity in ICs 
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during inflammation may contribute to the motility disorders (Altdorfer et 
al. 2002). 
 
1.10. Calcium signaling in myenteric neurons  
Calcium plays an important role in the regulation of a great variety of 
neuronal processes including neurotransmission, excitability, regulation 
of enzymatic activities or gene expression (Berridge 1998). Like other 
cells, the free cytosolic Ca2+ concentration of neuronal cells is kept low 
by a series of plasma membrane pumps or exchangers and several 
intracellular Ca2+ sequestering units such as endoplasmic reticulum 
(ER) and mitochondria (Kennedy 1989, Figure 1.2). 
The neuronal endoplasmic reticulum contributes to the Ca2+ signaling by 
acting either as a source or as a sink of Ca2+ (Miller 1991, Berghe et al. 
2002). The ER is a continuous membrane network that extends 
throughout the neuron and interacts with the plasma membrane to 
control a wide range of neuronal processes (Berridge 1998). 
Ca2+ is released from the ER upon activation of either the inositol 1,4,5-
trisphosphate (IP3) receptors (IP3Rs) or the ryanodine receptors (RYRs; 
Simpson et al. 1995). These receptors are sensitive to Ca2+ and display 
the phenomenon of Ca2+-induced Ca2+ release, which is responsible for 
amplifying Ca2+ signals from the outside. The entry of Ca2+ from the 
outside is regulated by voltage-operated channels (VOCCs) or by 
receptor-operated channels. Metabotropic neurotransmitters stimulate 
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the formation of IP3, which acts on IP3Rs to release Ca2+ from the ER 
(Berridge 1998). The ryanodine receptors are sensitive to the second 
messenger cyclic ADP ribose, which enhances Ca2+ release (Galione 
1994). 
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Figure 1.2: Neuronal calcium signaling (from Berridge 1998). VOC = voltage 
operated channel; ROC = Receptor operated channel; PtdIns4,5P2 = 
Phosphatidylinositol 4,5-biphosphate; DAG = Diacylglycerol; IP3 = inositol 
1,4,5-trisphosphate; IP3R = inositol trisphosphate receptor; RYR = Ryanodine 
receptor; CICR = Calcium-induced calcium release; Ca2+ = Calcium ions. 
 
The role of Ca2+ in modulation of neuronal excitability is mediated by 
changes in the membrane potential. The afterhyperpolarization (AH), 
which has been identified in myenteric neurons to regulate the rate of 
firing by interrupting high frequency discharges, arises from the opening 
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of Ca2+-activated K+ channels; the underlying rise of the cytosolic Ca2+ 
concentration is mediated by an influx into the cell via VOCCs and/or a 
release of stored Ca2+ from the ER (Berridge 1998). However, Ca2+ has 
also been implicated in depressing neuronal activity. Modification in the 
amplitude, or spatial and temporal presentation of Ca2+ signals may 
account for this. 
A localized rise in the Ca2+ concentration can originate from channels in 
the plasma membrane or on the internal stores. These signals can 
either activate highly localized cellular processes in the immediate 
vicinity of the channels or produce a Ca2+ wave that spreads throughout 
the cell to activate processes at a global level. This phenomenon may 
explain how Ca2+ signals arising locally near the plasma membrane 
activate potassium channels and cause the muscle to relax, whereas 
elementary release events deeper in the cell create global Ca2+ signals 
and then the muscle contracts (Berridge et al. 1998). 
Since my work deals with the effect of NO on myenteric neurons with 
regard to voltage-operated calcium channels, these channels are 
described in more detail below. 
 
Voltage operated calcium channels 
Voltage-operated calcium channels mediate Ca2+ entry into cells in 
response to membrane depolarization and they are the signal 
transducers that convert electrical signals in the cell membrane into an 
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increase in the concentration of the intracellular second messenger 
Ca2+ (Catterall 2000). Multiple types of Ca2+ currents have been 
identified by their physiological and pharmacological properties and 
have been correlated with cloned Ca2+ channel subunits characterized 
by expression in vitro (Catterall 2000). The Ca2+ channels that have 
been characterized biochemically are complex proteins composed of 
four or five distinct subunits. The amino acid sequence of the α1 subunit 
is organized in four repeated domains (I-IV), each of which contains six 
transmembrane segments (S1-S6), and a membrane associated loop 
between the transmembrane segments S5 and S6. The S4 segments of 
each homologous domain serve as voltage sensors for activation, 
moving outward and rotating under the influence of the electric field and 
initiating a conformational change that opens the pore. The S5 and S6 
segments and the membrane-associated pore loop between them forms 
the pore lining of the voltage-gated ion channels. The narrow external 
pore is lined by the pore loop and is responsible for Ca2+ selectivity. The 
inner pore is lined by the S6 segments, which form the binding sites for 
the pore-blocking Ca2+ antagonists. An intracellular β-subunit and a 
transmembrane, disulfide-linked α2δ-subunit complex are component of 
most types of Ca2+ channels. A γ-subunit has also been found in 
skeletal muscle Ca2+ channels and related subunits are expressed in 
heart and brain (Catterall 2000).  
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Although these auxillary subunits modulate the properties of the channel 
complex, the pharmacological and electrophysiological diversity of Ca2+ 
channels arises primarily from the existence of multiple α1-subunits 
(Hofmann et al. 1994). Mammalian α1 subunits are encoded by at least 
ten distinct genes and are grouped into three subfamilies. The Cav1 
subfamily (Cav1.1 to Cav1.4) includes channels containing α1C, α1D, 
α1F, α1S, which mediate L-type Ca2+ currents in different tissues. The 
Cav2 subfamily (Cav2.1 to Cav2.3) includes channels containing α1A, 
α1B, α1E, which mediate P/Q-,N-, and R-type Ca2+ currents, 
respectively. The Cav3 subfamily (Cav3.1 to Cav3.3) includes channels 
containing α1G, α1H, α1I, which mediate T-type Ca2+ currents (Catterall 
et al. 2003). 
extracellular
intracellular
 
 
Figure 1.3: Transmembrane organization of the calcium channel subunits 
(from: www.sigmaaldrich.com). 
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Calcium currents have diverse physiological and pharmacological 
properties. L-type Ca2+ currents require a strong depolarization for 
activation, are long lasting and are blocked by the organic antagonists 
dihydropyridines and phenylalkylamines (Sher et al. 1991). L-type Ca2+ 
currents in neurons are important in regulation of gene expression and 
in integration of synaptic inputs (Bean 1989). N-type, P/Q-type, and R-
type Ca2+ currents also require strong depolarization for activation. They 
are insensitive to L-type Ca2+ channel blockers, but are blocked by 
specific polypeptide toxins from snail and spider venoms. They initiate 
neurotransmission at synapses and mediate calcium entry into cell 
bodies and dendrites (Catterall et al. 2003). The low voltage-activated 
T-type Ca2+ currents develop only transiently and are resistant to both 
organic antagonists and to the snake and spider toxins. They are 
involved in shaping the action potential and controlling patterns of 
repetitive firing (Catterall et al. 2003). 
The presence of these types of VOCCs was shown in myenteric 
neurons immunohistochemically (Kirchgessner and Liu 1999) and 
pharmacologically in rat and guinea pig small intestine (Schäufele and 
Diener 2005, Bian et al. 2004). 
 
Nitric oxide has been identified to be one of the key messengers 
govering the overall control of Ca2+ homeostasis in a number of cell 
systems (Clementi 1998). Several evidences have indicated that NO 
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affects Ca2+ signalling via different pathways. Release of Ca2+ from 
intracellular stores by action of NO has been defined. For example, in 
hepatocytes NO activates IP3 receptors via G-kinase phosphorylation of 
these receptors leading to release Ca2+ from the endoplasmic reticulum 
(Rooney et al. 1996). in addition, modulation of voltage-operated 
calcium channels by NO has been demonstrated in several cell types, 
so it has been shown that NO modulates calcium influx through P/Q-
type calcium channels in rat brain by inhibition of these channels 
(Petzold et al. 2005) and vice versa, activation of VOCCs by NO has 
been demostrated in other studies, for example, in rat sympathetic 
neurons (Chen and Schofield 1995).  
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1.11. Aim of the study 
 
The present work aimed to investigate the action of the neurotransmitter 
nitric oxide on myenteric ganglia in the rat small intestine. The following 
questions should be answered: 
 
• Does NO affect Ca2+ homeostasis in rat myenteric ganglia? 
• Is this action mediated by Ca2+ channels in the cell membrane or 
mediated by intracellular stores of calcium? 
• Which types of voltage-operated calcium channels are involved in 
this NO action? 
• Which nitric oxide synthase isoforms are responsible for nitric 
oxide synthesis in myenteric ganglia? 
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2. Material and Methods 
2.1. Animals 
The experiments were carried out on five to twelve days old Wistar rats 
of both sexes. The rats were supplied by the Institute for Veterinary 
Physiology of the University of Gießen. The animals were kept in a 
housed room with a temperature of 22.5 °C, an air humidity of 50 – 55 
%, and a 12 h :12 h light-dark cycle. The rats had access to water and 
standard diet ad libitum. 
 
2.2. Solutions 
2.2.1. Solutions for tissue preparation and cell culture 
The isolation of the muscle layer containing the myenteric plexus was 
carried out in N-(2-hydroxyethyl)-piperazine-N´-(2-ethanolsulfonic acid) 
(= HEPES; 25 mmol.l-1)-buffered Dulbecco´s modified Eagle´s Medium 
(DMEM). Before use, the medium was supplemented with L-glutamine 
(final concentration: 4 mmol.l-1), gentamycin (final concentration: 20  
mg.l-1), and metronidazol (final concentration: 5 mg.l-1). For the 
dissociation of the myenteric ganglia from the tunica muscularis, the 
tissue was incubated with the enzyme collagenase type 2 (268 - 273 
units.mg–1), which was dissolved in DMEM (final collagenase 
concentration 1 mg.ml-1).  
The obtained ganglia were incubated for one to three days in Start-V® 
medium (Biochrom AG, Berlin, Germany), a neuron specific medium, 
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supplemented with fetal calf serum (FCS; 10 % v/v). The medium was 
supplemented with the antibiotics penicillin G (100,000 units.l-1) and 
streptomycin (100 mg.l-1). In some experiments, the proinflammatory 
cytokine TNF-α (Tumor necrosis factor-α) was added to the cell culture 
medium in a concentration of 100 ng.ml-1. For this purpose, TNF-α (1 
µg) was dissolved in a stock solution of 1 ml autoclaved aqua dest with 
1 mg bovine serum albumin (BSA). 
 
2.2.2. Solutions for the fura-2 experiments 
For the superfusion of the myenteric ganglia during the imaging 
experiments, a standard Tyrode solution was used containing (in  
mmol.l-1): NaCl 140, KCl 5.4, HEPES 10, CaCl2 1.25, MgCl2 1, glucose 
12.2. The pH of this solution was adjusted to 7.4 with NaOH/HCl. For 
the Ca2+-freeTyrode solution, CaCl2 was omitted. 
 
2.2.3. Solutions for immunohistochemistry 
The standard solution for these experiments was a phosphate-buffered 
saline (PBS) containing (in mmol.l-1 ) NaCl 130, Na2HPO4 8, NaH2PO4 
1.2. The pH was adjusted to 7.4 with NaOH/HCl. This solution was 
needed to wash the ganglionic preparation during the experiments from 
the remaining fixation solution and from the antibody-containing 
solutions. It was also used as the basic solution to prepare the blocking 
and the antibody-containing solutions. In addition, a 360 mmol.l-1 
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phosphate buffer (PB) containing (in mmol.l-1) Na2HPO4 282 and 
NaH2PO4 76 was used as a stock solution for preparation of 
paraformaldehyde solution (PFA). Paraformaldehyde (4 %, w/v), diluted 
in 135 mmol.l-1 phosphate buffer, was used for the fixation of the myenteric 
ganglia. To prepare this solution, an equivalent amount of PFA (40 g) 
was weighted under the lab bench and dissolved in 1 l aqua dest. at 60 
°C by permanent stirring and addition of NaOH. This solution had to be 
clear before it could be diluted with phosphate buffer up to a final 
concentration of 150 mmol.l-1. pH was adjusted to 7.4 with NaOH/HCl. 
To permeabilize the cells and block unspecific binding sites, a Triton-X-
containing phoshate-buffered saline (PBS-T) with 0.05 % (v/v) Triton-X 
was used, which was supplemented with 10 % (v/v) FCS. 
 
2.3. Tissue preparation and cell culture 
2.3.1. Tissue preparation 
The rats were decapitated by a scissor (approved by 
Regierungspräsidium Gießen). The animals were fixed on a plate with 
needles through the foots, and the abdominal cavity was opened 
through a midline incision. All following steps were performed under a 
binocular microscope (Olympus SZX9; Olympus, Hamburg, Germany). 
In order to remove the small intestine, the gut was cut off at the end of 
the rectum with a small scissor and carefully pulled out by a forceps, 
without injuring the bowel, until 5 cm distal to the pylorus of the stomach 
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and then cut off. Then the intestine was cleaned from the connective 
tissue by cutting away the mesentery as close as possible to the gut 
(Schäfer et al. 1997). The small intestine was separated from the colon 
through a cut proximal to the junction of the caecum. 
The obtained gut preparation was transferred to a petridish of 35 mm 
diameter containing the preparation medium (DMEM). The muscle layer 
with adherent myenteric plexus was isolated from the mucosa by using 
two fine forceps (Dumont Nr. 5; Plano, Wetzlar, Germany). While fixing 
one end of the gut with one forceps, the muscularis was carefully pulled-
away (“stripped”, similar as removing a stocking from a leg) until the end 
of the small intestine. 
The obtained tissue was transferred to a 1.5 ml tube (Eppendorf, 
Hamburg, Germany) containing 500 µl DMEM and 500 µl collagenase 
stock solution (see above). It was incubated at 37 °C in a humidified 
atmosphere of 95 % O2 and 5 % CO2 (v/v) for enzymatic digesion for 2 
h. After that time, the tube was vortexed for 30 s. The content of the 
Eppendorf tupe was gradually screened in a dish with DMEM under the 
microscope. Depending on the age of the animal used, some ganglia, 
forming net-like structures, could already be separated from the tunica 
muscularis at this stage of the praparation. By using a 20 µl pipette, the 
ganglia were collected and placed in a dish with DMEM on ice. 
The partially digested muscle pieces were again transferred into a fresh 
collagenase solution and incubated for a further 2 h period. This 
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process could be repeated up to 4 times, however, by reducing the 
exposure time of the collagenase to periods of 30–60 min. Finally the 
isolated ganglia were transferred with a pipette into an autoclaved 
Eppendorf tube and centrifuged at 600 rpm for 10 min. 
 
2.3.2. Culture of myenteric ganglia 
All following steps were performed at the flow bench. For the culture of 
the myenteric gangila, conventional four-well-chamber (Nunc, 
Wiesbaden, Germany) and poly-L-lysine-coated glass coverslips (see 
below) were needed. First the supernatant was carefully sucked away 
with a pipette, and the pellet was re-suspended into Start-V® medium 
supplemented with 10 % (v/v) FCS. After passing the cell suspension a 
few times through the pipette to separate the myenteric ganglia into 
smaller pieces, the cells were transferred (50 µl for each well) into the 
culture chamber with the coverslips and incubated at 37 °C for 1 h to let 
the cells settle down on the coverslips. When the complete dissociation 
of the cells was desired, the cell suspension was passed through a 
needle (0.4 mm diameter). Finally the Start-V® volume in each well was 
completed to 500 µl. The chamber was replaced into the incubator; the 
cultured ganglia could be used for the experiment the next day. 
 
2.3.3. Coverslips coating 
For coating the coverslips, poly-L-lysine (molecular weight > 300,000 D) 
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was used. The round cover glasses (13 mm; Nunc, Wiesbaden, 
Germany) were placed in 70 % (v/v) isopropyl alcohol at least two h to 
prevent a contamination of the preparation. Then they were washed 
thoroughly with autoclaved aqua dest. and transferred to a light 
protected tube (50 ml, Nunc GmbH, Wiesbaden, Gemany) with poly-L-
lysine (0.1 mg.ml-1) diluted 1 : 5 in aqua dest. The coverslips were 
shaken on a shaker for about 3 h. Subsequently, the coverslips were 
carefully washed with aqua dest. and dried under light protection. 
 
2.4. Imaging experiments 
2.4.1. Principles of the method 
In order to measure the cytosolic free Ca2+ concentration [Ca2+]i, a 
microscopic imaging technique was used based on the Ca2+-sensitive 
indicator dye, fura-2. Fura-2 is the most popular Ca2+ indicator for 
microscopy of individual cells (Tsien 1989). Compared to the previous 
widely used dye, quin-2, fura-2 exhibits stronger changes in wavelength 
upon binding of Ca2+, a higher selectivity for Ca2+ over other divalent 
cations, and it bleaches much less quickly than quin-2 (Grynkiewicz et 
al. 1985). Fura-2 belongs to the ratio indicator dyes or wavelength 
shifting dyes, which after complexing Ca2+ change either excitation or 
emission wavelength. Fura-2 binds Ca2+ with shifting its excitation 
spectrum from a wavelength of 360 nm to a wavelength of 340 nm 
(Figure 2.1). 
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Figure 2.1: Excitation wavelengths of fura-2 at different free Ca2+ 
concentrations. Em = Emission wavelength.  
From: www.probes.invitrogen.com/handbook/figures/0554.htm. 
 
 
Consequently, both the free and the bound forms of the dye 
fluorescence strongly, so that they can be used for a ratio 
measurement, that means the alteration of the excitation wavelength 
between the two prefered wavelengths permits the measurement of the 
ratio of the Ca2+ bound dye and the free dye. From this value, the 
cytosolic Ca2+ concentration can be calculated (Tsien et al. 1985). 
The green emission from fura-2 peaks at 505 – 520 nm and does not 
shift significantly after Ca2+ binding. The two preferred excitation 
wavelengths were 340 nm and 380 nm, where the ratio signal shows 
the largest dynamic range (Tsien 1989). This ratio method cancels out 
the effects of many factors that can appear during measurement at 
single wavelength as with quin-2, i.e. the fluorescence intensity from 
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excitation at single wavelength is dependent on the dye concentration, 
the cell thickness, and instrumental factors such as lamp intensity. The 
dye concentration varies from cell to cell and decreases gradually due 
to bleaching and leakage, the thickness of cells varies from cell to cell 
and from position to position within a cell, and the illumination intensity 
varies over the field of view of a microscope. The ratio operation 
cancels out these uncertainties by measuring the shape or wavelength 
distribution of the fluorescence spectrum rather than its absolute 
amplitude (Tsien et al.1985). 
From the ratio signal, the cytosolic Ca2+ concentration can be calculated 
using the so-called Grynkiewicz equation (Grynkiewicz et al.1985). 
 
[Ca   ]i = 
KD * β * (R - Rmin)
(R - Rmax)
2+
 
 
Where: 
KD = dissociation constant 
ß = fluorescence during excitation at 340 nm (at 0 µmol.l-1 Ca2+) divided 
by the fluorescence during excitation at 380 nm (at 39.8 µmol.l-1 Ca2+) 
R = measured ratio 
Rmin ,Rmax = ratio at 0 and 39.8 µmol.l-1 Ca2+, respectively. 
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Fura-2 has a high selectivity for Ca2+ over Mg2+ and other divalent 
cations. It is only poorly affected by intracellular pH changes. It is 
derived from the parent compound 1,2-bis(O-aminophenoxy)ethane-
N,N,N’,N’-tetraacetic acid (BAPTA), which is a derivative of the Ca2+ 
chelator EGTA (ethylene-glycol-bis(β-aminoethyl ether)-N,N,N’,N’-
tetraacetic acid), to which refers the good discrimination between 
Mg2+/Ca2+ of the fura-2, i.e, the binding cavity has the right size for Ca2+ 
but can not envelope Mg2+, because the carboxylates at each end of the 
chain will butt into each other (Tsien 1980) (Figure 2.2). 
 
 
 
Figure 2.2: Structure of fura-2. From: www-user.tu-
chemnitz.de/awill/diplom/fura2.htm. 
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Monovalent cations do not form detectable complexes, probably 
because their charge is inadequate to bind the negative carboxylates 
(Tsien 1989). Fura-2 has a dissociation constant for Ca2+ of 
approximately 224 nmol.l-1 and can be used to measure intracellular 
Ca2+ concentrations ranging from about 2.24 to 22400 nmol.l-1. The 
dissociation constant is defined as the value, at which 50 % of the 
fluorescent dye has bound the target ion. This low affinity for Ca2+ 
permits measure of high [Ca2+]i values up to several micromolar (Tsien 
et al. 1985). Since the basal cytosolic Ca2+ averages in general 100 
nmol.l-1, fura-2 can encompass the increase in [Ca2+]i under most 
physiologic situations. 
 
Fura-2 is a charged molecule which can not permeate the intact cell 
membrane. Therefore, for loading the cells, the liphophilic fura-2-
acetoxymethylester (fura-2/AM) was used, in which the four carboxylate 
groups are masked with ester groups. Inside the cell, the ester groups 
are hydrolysed through nonspecific esterases and the orginal chelator is 
trapped in the cytosol (Tsien 1981). 
The accurate calculation of intracellular Ca2+ concentration by the 
Grynkiewicz equation (see above) is not absolutely reliable, since the 
fluorescence signal is influenced by many intracellular factors such 
intracellular proteins or osmolarity (Baylor et al. 2000). Therefore, in this 
work (as it is meanwhile standard for most studies using fura-2), only 
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changes in the fura-2 signal ratio as indicator for [Ca2+]i are given. 
 
2.4.2. The experimental setup 
An inverted light microscope was used (Olympus IX-50, Olympus, 
Hamburg, Germany), equipped with an epifluorescence setup and an 
imaging analyse software (Till Photonics, Martinsried, Germany). A 
monochromator is the central unit of the system. The light from an 
integrated xenon light source, which is adjusted to the desired 
wavelengths with the help of a control unit of the monochromator and 
the imaging software, is collected through lenses and mirrors to 
generate the desired excitation wavelength. The excitation light is 
focused onto the lightguide of the monochromator. The monochromatic 
light is linked to the microscope via an epifluorescence condensor. A 
dichroic mirror receives the excitation light and reflects it through the 
microscope objective to the cells. The emitted light from the cells 
passes the mirror across an emission filter, then it is received from a 
charge-coupled device (CCD) camera and converted into digitized 
images. The camera is connected to a frame grabber in the computer. 
In the computer, the image data are processed before they are 
displayed on the screen during the so-called live mode of the imaging 
software (Figure 2.3). 
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Figure 2.3: Schematic of the imaging apparatus 
 
 
2.4.3. Experimental procedure 
The cells were loaded with fura-2/AM (6 µl, 5 µmol.l-1 final concentration) 
in DMEM (total volume: 500 µl) with pluronic acid (0.05 % (w/v) final 
concentration) for 60 min at room temperature. Pluronic acid is a 
detergent; it was used to improve the solubility of fura-2/AM. This 
process was achieved in the experimental chamber and in darkness, 
because of the sensitivity of fura-2 to light. After rinsing the cells three 
times with fresh DMEM, the coverslip with the attached cells was fixed 
by screws over a hole in the bottom of a selfcreated chamber with a 
Computer
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volume of 3 ml. The chamber was transferred to the stage of the 
microscope. After perfusing the cells with Tyrode solution to remove the 
DMEM, a suitable field of cells was chosen for the measurement. After 
the connection of the microscope to the camera and start of the 
software, several cells whithin the image analysis software were chosen 
(region of interest) and marked. Now the recording of the image could 
begin by alternative exposure of the cells to the selected excitation 
wavelength (340 nm and 380 nm) at an emission wavelength of 510 nm. 
The exposure time was 20 ms for each excitation wavelength. This was 
repeated every 5 s (sampling rate 0.2 Hz). Baseline fluorescence was 
recorded at the beginning of the experiment (superfusion with Tyrode 
solution for a few minutes), then the subsequent [Ca2+]i changes upon 
drug administration were determined. 
An infusion set was used to superfuse the preparation hydrostatically 
(perfusion rate about 1 ml.min-1) throughout the experiment. 
 
2.5. Polymerase chain reaction (PCR) 
Polymerase chain reaction was developed by Kary B. Mullis in 1985 
(Mullis was a scientist for the Cetus corporation in California), he 
awarded the Nobel prize in chemistry in 1993 for his discovery of the 
PCR method (Newton and Graham 1997). 
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2.5.1. Basic principles of PCR 
PCR is a technique for amplifying specific DNA sequences (targets) that 
is currently used in a wide variety of molecular biology applications 
(Mullis and Faloona 1987).The amplifying of a DNA sequence (double 
stranded) is performed in three steps. In the denaturing step, the DNA 
sequence is separated through application of a high temperature to 
about 95 °C into two single strands termed templates, which are in the 
annealing step hybridized with a short single stranded DNA molecule 
called primer. The primer must to be long enough (18 to 24 nucleotides) 
to reduce the probability of the sequence binding at non target sites 
(Saiki et al. 1985). Two different primers bind after cooling down the 
reaction mixture to about 50 - 65°C, a sense (or forward) and an anti-
sense (or backward) primer. Only the template molecules that have a 
sequence complementary to the primer will recognize and bind the DNA 
polymerase. The last step is the polymerization reaction, an extension 
of the primer-template molecule at 72 °C through the thermostable 
(Taq) DNA polymerase (a frequently used enzyme isolated from the 
heat stable bacterium, Thermus aquaticus) by binding a complementary 
nucleotide to each nucleotide in the template strand in the presence of 
deoxynucleotides triphosphates (dNTPs, i.e. a mixture of dATP, dTTP, 
dGTP, dCTP) and magnesium chlorid, in the direction from the primer to 
the other end. The cycle of three steps is repeated 30 - 50 times and the 
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DNA molecules that were synthesized in a cycle are used as templates 
in the following one (Stolovitzky and Cechi 1996) (Figure 2.4). 
 
DenaturationDenaturation
DS
DNA
Annealing
Extension
95° C
60° C
72° C
 
Figure 2.4: Polymerase chain reaction. DS-DNA = double-stranded DNA; P = 
Primer (from www.flmnh.ufl.edu/cowries/PCR). 
 
 
2.5.2. Gel electrophoresis of DNA 
Electrophoresis through an agarose gel is the standard method to 
separate, identify and purify DNA fragments (Sharp et al. 1973). 
Applying an electric field across the gel lets the DNA, which is 
negatively charged at neutral pH, migrate toward the positive electrode. 
The location of the DNA within the gel can be controlled directly by 
staining the sample with a low concentration of the fluorescent dye, 
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ethidium bromide, which intercalates between base pairs of the DNA. 
Bands containing as little as 1 – 10 ng of DNA can be detected by 
exposure of the stained gel to the ultraviolet light. TAE (Tris-
acetate/EDTA buffer; composition see below) is the most commonly 
used buffer. The electrophoretic mobility of DNA is affected by the 
composition and the ionic strength of the electrophoresis buffer, in the 
absence of buffer the electrical conductance is minimal and DNA 
migrates slowly. It is important to use the same batch of electrophoresis 
buffer in both the electrophoresis tank and the gel, as small differences 
in ionic strength can greatly affect the motility of DNA fragments 
(Sambrook et al. 1989). 
 
2.5.3. Experimental procedure 
The experiment should be performed under sterile conditions to prevent 
microbial contamination which can be a source of RNAse . 
 
RNA extraction  
For eNOS and iNOS isoform determination, the total RNA was extracted 
from samples using a commercial kit (Rneasy kit, Qiagen, Heiden, 
Germany). 
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1. Lysis of the cells 
First the cells were centrifuged at 600 rpm for 10 min. Subsequently, the 
supernatant was removed, the pellet was resuspended in 600 µl lysis 
buffer (RTL-buffer from the Rneasy kit) with β-mercaptoethanol (1% 
(v/v)). Because the latter product is toxic, this step had to be performed 
under the lab blech. By applying a thorough vortexing, the cell lysate 
was completely homogenized. 
 
2. Isolation of RNA 
700 µl of the homogenized sample was transferred into a Qia shreder 
tube (provided with the kit) and centrifuged at 1500 rpm for 2 min. The 
lysate in the lower part of the tube was sealed (with cover provided with 
the kit) and centrifuged for 3 min at 1500 rpm. The supernatant was 
transferred to a new tube (Eppendorf, Hamburg, Germany) followed by 
adding the same volume of ethanol (70 % (v/v)) and thoroughly 
vortexing. 700 µl of the sample was pipetted to Rneasy-Mini spin 
column (provided by the kit) and centrifuged for 45 s at 1500 rpm. The 
supernatant was removed and 700 µl RW1 buffer (provided with the kit) 
was added to a spin column and centrifuged for 45 s at 1500 rpm. After 
the tube with the supernatant was removed, the spin column was placed 
on a new 2 ml tube and 500 µl RPE buffer (provided with the kit; diluted 
in 96-100 % (v/v) ethanol, 200 µl/800 µl respectively) was added 
followed by 45 s centrifugation at 1500 rpm. RW1 and RPE are used for 
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elution of RNA under low-salt condition. This step was repeated by 
adding 500 µl diluted RPE buffer after the supernatant was sucked 
away and centrifugation for 2 min. The supernatant was removed. The 
spin column was pulled carefully out from the lower tube and placed on 
a new 1.5 ml tube followed by adding 30–50 µl RNAse free DEPC-water 
(diethylpyrocarbonate; 1 ml DEPC/l Aqua dest) and centrifugation for 1 
min at 8000 rpm. The supernatant with the prepared RNA can be stored 
at –20 °C. 
 
3. Isolation of mRNA (poly A+-RNA) 
The isolation of mRNA from the total RNA was carried out through 
binding of mRNA to oligotex-resin in OBB-buffer (provided with the kit) 
under high salt condition and the elution in OEB-buffer (provided with 
the kit) under low salt condition using OligoTex® Qiagen. 
 
The Oligotex-suspension and the OEB-buffer were being warmed at 37 
°C and 70 °C, respectively in a heating block. 250 µl RNAse free water 
was added to the total RNA sample tube followed by adding 250 µl 
OBB-buffer and 15 µl of warmed Oligotex-Suspension. The mixture was 
thoroughly vortexed and incubated for 3 min at 70 °C in a heating block. 
After cooling of the mixture for 10 min at room temperature 
(hybridisation of mRNA to the OligoT30-Nucleotide in Oligotex-resin), 
the tube was centrifuged for 2 min at 15,000 rpm and the supernatant 
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was carefully removed. Following resuspension of the Oligotex-mRNA-
pellet in 400 µl OW2-buffer and strong vortexing, the suspension was 
transferred to a small spin column placed on a 1.5 ml tube and 
centrifuged for 1 min at 15,000 rpm. The tube with the supernatant was 
removed and the spin column was placed on a new tube. After adding 
400 µl OW2-buffer, the last step was repeated. The spin column was 
placed on a new tube, 20 µl from prewarmed OEB-bufffer was added 
and a repetitive pipetting applied to resolve the resin from the column in 
the buffer suspension. The tube was centrifuged at 15,000 rpm for 1 min 
followed by adding 20 µl of warmed OEB-buffer and the last step was 
repeated. After centrifugation, the spin column was removed, and the 
mRNA in the supernatant could be used in RT-PCR. 
 
Reverse transcriptase reaction 
Using cMaster RT-kit (Eppendorf, Hamburg, Germany) cDNA was 
reverse transcribed from poly A+-RNA in a reaction mixture of 20 µl. All 
substances of cMaster kit had to be placed on ice and centrifuged 
before use by the mean of a table-top centrifuge (Qualitron Dw-41). 
 
The procedure 
The constituents of the cMaster kit were pipetted in a sterile tube as 
followed: 3.5 µl RNase free water, 4 µl RTplus buffer (25 mmol.l-1 Mg2+), 
2 µl dNTPs (10 mmol.l-1), 2 µl cMasterRt enzyme, 0.5 µl primer RNAse 
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inhibitor (provided with the cMaster kit). In another tube were 
transferred: 6 µl poly A+-RNA and 2 µl Oligo dT Primer (Promega 
C110A), they were incubated for 5 min at 65 °C to resolve the base 
pairs in single strands. The tube was immediately placed on ice. After 
adding of the 12 µl mastermix, the reaction mixture was transferred to a 
thermocycler and run at 42 °C for 60 min. 
The resultant of the reverse transcriptase reaction, the cDNA, was 
immediately diluted (1:10) in DNase-RNase-free water (Sigma, 
Taufkirchen, Germany) and determined using a spectrophotometer at 
λ = 260 nm. The cDNA could be stored at -20°C. 
 
Isolation of RNA of the nNOS isoform 
The total RNA was extracted from cell samples using Trizol reagent 
(Invitrogen, Karlsruhe, Germany) according to the manufacturer’s 
instructions. Isolation of RNA by means of this reagent is an 
improvement to the single-step RNA isolation, wich is free of protein and 
DNA contamination. 
 
The procedure 
1. Homogenization 
The cells were pelleted by centrifugation and lysed in 1 ml Trizol 
reagent. The cell lysate was completely homogenized by passing it 
several times through a pipette. 
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2. Phase separation 
The homogenized sample was incubated for 5 min at room temperature. 
Then 200 µl of chloroform was added. The tube was thoroughly shaken 
for 15 s and incubated at room temperature for 2 min. The sample was 
centrifuged at 12,000 rpm for 15 min at 4 °C. Following centrifugation, 
the mixture was separated into three layers, a lower, a middle and a 
colorless upper aqueous layer. RNA is exclusively found in the upper 
layer. 
 
3. RNA precipitation 
The aqueous phase was transferred into a new tube. 500 µl of isopropyl 
alcohol was added to precipitate the RNA. The sample was incubated at 
room temperature for 10 min and centrifuged at 12,000 rpm for 10 min 
at 4 °C. 
 
4. RNA wash 
The supernatant was removed and RNA was washed with 1 ml 75 % 
(v/v) ethanol. The sample was mixed by vortexing and centrifuged at 
7,500 rpm for 5 min at 4 °C. 
 
5. Redissolving the RNA 
The RNA pellet was partially dried by air-drying for 5 - 10 min and 
dissolved in 30–50 µl RNase free water by passing the solution a few 
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times through the pipette tip. The RNA sample was incubated at 55 to 
60°C for 10 min. This RNA was used in reverse transcriptase reaction 
as described above. 
 
2.5.4. The PCR reaction 
cDNA was amplified by using Eppendorf Master mix (2.5 x) in a total 
volume of 25 µl with 1.25 U Taq DNA polymerase, 200 µmol.l-1 dNTPs 
mixture, and MgCl2 (1.5 mmol.l-1 or 2.5 mmol.l-1 or 3.5 mmol.l-1). Sense 
and antisense primer were used against rat eNOS, nNOS, iNOS 
(Schricker et al. 1996) and GAPDH (a constitutively expressed gene 
used as a control for the efficiency of cDNA synthesis). They were 
obained from MWG Biotech (Ebersberg,Germany) and are listed in 
Table 2.1.  
The PCR amplification protocol was as follows: 10 min at 94 °C, 40 
cycles with 1 min of denaturation at 94 °C, 1 min of annealing at 60 °C 
and 2 min of extension at 72 °C followed by a final elongation for 10 min 
at 72°C on a thermal cycler (Eppendorf, Hamburg, Germany). The 
amplified products were electrophoresed on 1.5 % agarose gel. 
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Table 2.1. Sequences of sense and antisense primers of rat eNOS, nNOS, 
iNOS, and GAPDH. 
 
Target 
molecule 
Accession 
code 
Sence primer Antisense primer 
eNOS NM 000603 5´ - CTG CTG CCC 
GAG ATA TCT TC- 
3´ 
5´ - AAG TAA GTG AGA 
GAG CCT GGC GCA- 3´ 
nNOS NM 052799  
 
5´-GAA TAC CAG 
CCT GAT CCA -3´ 
5´-TCC AGG AGG GTG 
TCC ACC GCA-3´ 
iNOS 
 
NM 012611 5´-GCA GCT GTG 
CTC CAT AGT-3´ 
5´-GAT AGG ACG TAG 
TTC AAC AT-3´ 
GAPDH 
 
BC 059110 5´-ACG GGA AGC 
TCA CTG GCA TG-
3´ 
5´-CCA CCA CCC TGT 
TGC TGT AG-3´ 
 
 
2.5.5. Electrophoresis of the PCR products 
A 1.5 % (w/v) agarose gel was prepared by adding 100 ml 1x TAE 
buffer (Tris-acetate/EDTA; Molecular Probes, Ohio, USA) which 
consisted of Tris acetate 40 mmol.l-1, EDTA 1 mmol.l-1, pH 8.15) to 1.5 g 
agarose (peqlab, Erlangen, Germany). The mixture was heated and 
boiled until the agarose was dissolved and the suspension appeared 
clear. While the agarose cooled down, the electrophoresis apparatus 
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was installed by sealing the edges of the plastic plate with rubber bands 
and setting into the electrophoresis tank. The comb was positioned 0.5 
mm above the plate, so that a complete well was formed when the 
agarose was added. After removing the gel layer above, the agarose 
was poured into the mold. Bubbles within the gel and under the teeth of 
the comb had to be avoided. 
After the gel was set, the comb and the rubber were carefully removed 
and 1 x TAE buffer was added to a level of about 0.5 cm above the gel. 
After the DNA samples were mixed with 2 µl loading dye, they were 
pippeted (using a 10 µl pipette) into the slots and 5 µl of 50 bp-ladder 
was loaded into the first and the last slots. The lid of the electrophoresis 
tank was closed. The voltage supply was attached and the 
electrophoresis was run for 2.5 h. After the run, the electric current was 
turned off, the lid was removed and the gel was carefully transferred to 
stain with ethidium bromide. 
 
2.5.6. Visualization of DNA in agarose gel 
The amplified products were visualized by staining the gel through 
immersion in aqua dest. containing the fluorescent dye ethidium 
bromide (1 mg.l-1 ) for 10 min. The ethidium bromide not bound to DNA 
was removed by soaking the stained gel in water for 10 min. The DNA 
bands were visualized, photographed by exposing the gel to ultraviolet 
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light (302 nm) and quantified using an image analyzing software (Bio 
Capt; Vilber Lourmat, Marge-La-Vallée, France). 
 
2.6. Immunohistochemical experiments 
2.6.1. Principles of the method 
Immunohistochemistry is the in situ-detection of antigens in tissue 
sections and cells by specific monoclonal or polyclonal antibodies. 
Detection is obtained by visualization of antigens by a light microscopy-
detectable fluorochrome conjugated to the antibody. 
Immunohistochemistry enables visualization of the distribution and 
localization of specific cellular components within a cell or tissue.The 
most widely used methods of detection work with enzyme-antibody 
conjugates such as peroxidases or fluorophore-antibody labeled with 
fluorescent dyes such as Alexa-fluor. 
The antibodies used can be polyclonal or monoclonal. Polyclonal 
antibodies are antibodies isolated from whole serum after a secondary 
immune response has been stimulated by injecting an antigen in an 
animal. They are a heterogenous mixture of antibodies that recognize 
several epitopes of antigens, but the disadvantage of this type is that 
they may cause unspecific background fluorescence. Monoclonal 
antibodies, however, are isolated from specific immunocytes (plasma 
cells) after stimulation of a secondary immune response. These cells 
are cultured, if the cells are genetically identical, they produce 
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monoclonal antibodies, which exhibit greater specificity (Noll and 
Schaub-Kuhnen 2000). 
There are two strategies used for the immunohistochemical detection of 
antigens in a tissue, the direct and the indirect method. In the direct 
method, a labeled antibody reacts directly with the antigen in cells. This 
method is rapid and simple, but has the disadvantage that it depends on 
the production of labeled antibodies against every antigen of interest. 
For the indirect fluorescence, however, a secondary antibody 
conjugated with a marker is used to visualize the antigen-antibody 
complex. The secondary antibody must be directed against the 
immunoglobuline of the animal species in which the primary antibody 
has been raised. This method has a higher sensitivity compared to the 
direct approach, because there can be several reactions sites on the 
primary antibody, which react with the secondary antibody and produce 
a good signal. Another advantage of the indirect technique is that there 
is no need to generate specific secondary antibody for every primary 
antibody, so a secondary antibody raised against IgG of a certain 
species can be used with any primary antibody raised in this animal 
(Larsson 1988). 
I have determined NOS isoforms (nNOS, eNOS, iNOS) by using the 
indirect method in dissociated cells attached to coated coverslips. The 
determination of NOS isoforms in some experiments was combined with 
the differentiation between glia and neurons in the same preparation 
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using double labelling technique. So mouse monoclonal anti-PGP 9.5 
(protein gene product 9.5; Dianova, Hamburg, Germany) was used for 
labelling of the neurons. Mouse monoclonal anti-GFAP (glial fibrillary 
acidic protein; Chemicon, Hofheim, Germany) was used for labelling of 
glial cells. As secondary antibodies for both primary antibodies, Alexa-
conjugated goat anti-mouse polyclonal Alexa Flour®488 (Invitrogen, 
Karlsruhe, Germany) was used. For investigation of NOS isoforms, 
rabbit anti-bNOS (Becton Dickinson, Heidelberg, Germany), rabbit anti-
eNOS (Chemicon, Hofheim, Germany), rabbit anti-iNOS (Chemicon, 
Hofheim, Germany) and the secondary Cy3-conjugated donkey anti 
rabbit were used (Table 2.2). 
 
2.6.2. Experimental procedure 
The experiments were carried out in the culture chambers and at room 
temperature. The volume of the solution for rinsing and incubation of the 
preparation was 500 µl. After the incubation medium was sucked away, 
the preparation was washed 3 times for 2 min with PBS. The cells were 
fixed with freshly prepared 4 % (w/v) PFA solution for 15 min. The 
preparation was washed 3 times with PBS for 2 min. The cells were 
permeabilized and nonspecific sites were blocked by incubation of the 
preparation with 10 % (v/v) FCS in 0.05 % (v/v) Triton X-100/PBS for 60 
min. Subsequently, the cells were incubated with primary antibodies 
diluted in FCS-Triton/PBS at 4°C for 48 h. 
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Table 2.2: Primary and secondary antibodies used in staining the cultured 
myenteric cells 
 
Primary Host Dose Secondary Dose 
nNOS Rabbit 1:800 Donkey anti-rabbit CY3 1:800 
eNOS Rabbit 1:800 Donkey anti-rabbit CY3 1:800 
iNOS Rabbit 1:200 Donkey anti-rabbit CY3 1:800 
PGP 9.5 Mouse 1:500 Goat anti-mouse Alexa fluor 
488 
1:500 
GFAP Mouse 1:500 Goat anti-mouse Alexa fluor 
488 
1:500 
 
The negative control was performed by omitting the primary antibodies. 
After the cells were rinsed 3 times for 2 min with PBS-T, the incubation 
with secondary antibodies diluted in FCS-Triton/PBS (Cy3 conjugated 
donkey anti-rabbit, 1:800 and Alexa Flour goat anti-mouse, 1:500) for 2 
h at room temperature and in darkness was performed. After a washing 
step the cells were stained with the nuclear dye DAPI (4´,6-Diamidino-2-
phenylindol dilactat, 300 nmol·l-1) for 5 min followed by washing 3 times 
with PBS-T. The cells then were embedded using Citiflour® (glycerol-
PB, Newby Castleman, Leicester, UK) on object slides and covered. 
The cells were observed and photographed with a light microscope 
(Eclipse 80i, Nikon, Düsseldorf, Germany) equipped with a digital 
camera (Digital Sight DS-2MBWc, Nikon, Düsseldorf, Germany). 
Images were only analyzed qualitatively and no quantification of NOS-
positive cells was performed. 
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2.7. Chemicals 
Fura-2/AM (Molecular Probes, Leiden, The Netherlands), and pluronic® 
(BASF, Weyandotte, USA) were dissolved as stock in dimethylsulfoxide 
(DMSO). GEA 3162 (Axxora, Grünberg, Germany), SNP (Calbiochem, 
Bad Soden, Germany), NiCl2, CoCl2, verapamil and carbachol were 
dissolved in Tyrode solution. Nifedipine was dissolved in ethanol (final 
concentration 0.02 %, v/v), ω-conotoxine GVIA and ω-agatoxin IVA 
(both from Alomone, Jerusalem, Israel) were dissolved in Tyrode 
solution containing 1g.l-1 BSA. DAPI (4´,6-diamidino-2-phenylindol 
dilactate) was dissolved as stock in Aqua dest (final concentration 300 
nmol.l-1). If not indicated differently, drugs were obtained from Sigma 
(Taufkirchen, Germany). 
 
2.8 Statistics 
Results are given as means ± standard error of the mean (SEM) with 
the number (n) of investigated cells. For the comparison of two groups, 
either a Student’s t-test or a Mann-Whitney U-test was applied. An F-
test decided which test method had to be used. Both paired and 
unpaired two-tailed Student’s t-tests were applied as appropriate. When 
the mean values of more than two groups had to be compared, an one-
way ANOVA test was performed followed by analysis of linear contrasts 
with the test of Scheffé. 
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3. Results 
 
3.1. Effect of NO donors on the intracellular Ca2+ concentration in 
the myenteric ganglia 
After loading the myenteric ganglia with fura-2/AM, the lipophilic 
precursor of the Ca2+-sensitive dye fura-2, the response of these cells to 
an NO-donor such as GEA 3162 or sodium nitroprusside (for references 
of the drugs, see Schultheiss et al. 2002) was tested. First, the fura-2 
ratio signal was measured under baseline conditions, i.e during 
superfusion with Tyrode solution. Under these conditions, the fura-2 
ratio amounted to 0.43 ± 0.013 (n = 66). Subsequently, GEA 3162 (10-4 
mol.l-1) was administered. The NO donor induced a pronounced 
increase in the fura-2 ratio signal to 0.51 ± 0.018 (p < 0.05 versus 
baseline, n = 66; Figure 3.1, Table 3.1), indicating an increase in the 
cytosolic Ca2+ concentration. 
At the end of all fura-2 experiments, cell viability was checked by 
administration of either carbachol (5.10-5 mol.l-1), a cholinergic agonist, 
or of cyclopiazonic acid (CPA; 5.10-5 mol.l-1). Carbachol induces an 
increase in the cytosolic Ca2+ concentration via stimulation of nicotinic 
receptors (Rehn et al. 2004). Cyclopiazonic acid, however, acts as 
blocker of sarcoplasmic-endoplasmic reticulum Ca2+-ATPases 
(SERCA), which causes an increase in the cytosolic Ca2+ concentration 
by inhibiting the uptake of Ca2+ into intracellular Ca2+ stores (Moncoq et 
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al. 2005). All cells responding to carbachol or CPA were included in the 
statistical analysis. 
 
The effect of GEA 3162 was mimicked by another NO donor, sodium 
nitroprusside (Figure 3.2). 
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Figure 3.1: Administration of GEA 3162 (10-4 mol.l-1) induced an increase in 
the fura-2 ratio at cultured myenteric ganglia as shown in an original record 
(top). In average (bottom), the fura-2 ratio increased from 0.43 ± 0.01 under 
control conditions (black bar) to 0.51 ± 0.02 in the presence of GEA 3162 
(shaded bar; n = 66). Values are means ± S.E.M., * p < 0.05 versus control just 
prior administration of GEA 3162. Cell viability was confirmed at the end of 
each experiment by administation of carbachol (CCH; 5.10-5 mol.l-1).  
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Figure 3.2: The NO donor, sodium nitroprusside (10-4 mol.l-1; SNP) caused an 
increase in the fura-2 ratio at cultured myenteric ganglia as shown in an 
original record (top). In average (bottom), the fura-2 ratio signal increased from 
0.56 ± 0.047 under control conditions (black bar) to 0.60 ± 0.051 in the 
presence of SNP (shaded bar; n = 19). Values are means ± S.E.M., p < 0.05 
versus control just prior administration of SNP. Cell viability was confirmed at 
the end of each experiment by administation of the SERCA blocker, 
cyclopiazonic acid (CPA; 5.10-5 mol.l-1). 
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3.2. The effect of NO donors is dependent on the presence of 
extracellular Ca2+ 
In the next series of experiments, it should be determined whether the 
increase in the intracllular Ca2+ concentration induced by the NO-donors 
was caused by a Ca2+ release from intracellular stores or by a Ca2+ 
influx from the extracellular space. Therefore, the ganglia were 
superfused with a Ca2+-free Tyrode solution in order to prevent Ca2+ 
influx across the plasma membrane. All these experiments were 
performed with GEA 3162, the more potent of the two tested NO 
donors. 
In the absence of extracellular Ca2+, the action of the NO-donor on the 
fura-2 signal was completely suppressed (Figure 3.3). Cell viability was 
tested by administration of cyclopiazonic acid, which evoked an 
increase in the cytosolic Ca2+ concentration even in the absence of 
extracellular Ca2+ indicating that cell viability was preserved under these 
conditions. 
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Figure 3.3: Effect of GEA 3162 (10-4 mol.l-1) on the fura-2 ratio in the absence 
of extracelllular Ca2+ as shown in an original record (top). In average (bottom), 
GEA 3162 caused only a small, statistically insignificant increase of the fura-2 
ratio from 0.23 ± 0.01 under control conditions (black bar) to 0.24 ± 0.01 in the 
presence of GEA 3162 (shaded bar; n = 42; p > 0.05 versus fura-2 ratio in the 
absence of GEA 3162). Values are means ± S.E.M. Cell viability was 
confirmed at the end of each experiment by administation of the SERCA 
blocker, cyclopiazonic acid (CPA; 5.10-5 mol.l-1). 
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3.3. Involvement of voltage-dependent Ca2+channels 
The predominant Ca2+ transporters, which are responsible for an influx 
of Ca2+ across the plasma membrane in excitable cells such as neurons 
are voltage-dependent Ca2+ channels (Catterall et al. 2003). In order to 
investigate the possible involvement of these ion channels in the NO 
response at rat myenteric ganglia, the ability of different blockers of 
voltage-dependent Ca2+ channels to interfere with the NO response was 
tested. All blockers were used in concentrations which were known to 
exert a maximal effect at rat myenteric ganglia (Schäufele and Diener 
2005). 
Many types of voltage-dependent Ca2+ channels can be inhibited by 
divalent cations such as Ni2+ and Co2+ (N’Gouemo and Morad 2003). 
Pretreatment of the ganglia with Ni2+ (5.10-4 mol.l-1) nearly completely 
suppressed the action of a subsequent administration of GEA 3162 
(Figure 3.4, Table 3.1). 
 64
 
Fu
ra
-2
 ra
tio
 (3
40
 n
m
 / 
38
0 
nm
)
0
0.1
0.2
0.3
2 min
Tyrode CPA
NiCl2 (0.5 mM)
GEA
 
 
Fu
ra
-2
 ra
tio
 (3
40
 n
m
 / 
38
0 
nm
)
0
0.1
0.2
0.3
Co
ntr
ol
Ni
Cl
 2
GE
A
 
 
Figure 3.4: Effect of GEA 3162 (10-4 mol.l-1) on the fura-2 ratio in the presence 
of the non-specific Ca2+channel blocker Ni2+ (5.10-4 mol.l-1) as shown in an 
original record (top). In average (bottom), the fura-2 ratio signal changed from 
0.18 ± 0.01 under control conditions (black bar) to 0.17 ± 0.01 after the 
addition of Ni2+ (grey bar), and raised to 0.18 ± 0.01 in the presence of GEA 
3162 (shaded bar; n = 16; not significant). Values are means ± S.E.M. Viability 
of cells was tested by the SERCA-blocker, cyclopiazonic acid (5.10-5 mol.l-1). 
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A reduction of the GEA 3162 response was also observed in the 
presence of Co2+ (10-3 mol.l-1; Figure 3.5, Table 3.1), although the effect 
of this divalent cation was less pronounced compared to that of Ni2+. 
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Figure 3.5: Effect of GEA 3162 (10-4 mol.l-1) on the fura-2 ratio in the presence 
of the non-specific Ca2+ channel blocker Co2+ (10-3 mol.l-1) at rat myenteric 
ganglia as shown in an original record (top). In average (bottom), the fura-2 
ratio signal changed from 0.21 ± 0.01 under control conditions (black bar) to 
0.21 ± 0.01 after the addition of Co2+ (grey bar), and raised to 0.25 ± 0.01 in the 
presence of GEA 3162 (shaded bar; n = 34). Values are means ± S.E.M., * p < 
0.05 versus fura-2 ratio in the presence of Co2+. Viability of cells was tested by 
SERCA-blocker, cyclopiazonic acid (5.10-5 mol.l-1). 
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In order to differentiate the subtypes of the voltage-dependent Ca2+ 
channels involved, more specific inhibitors were tested. Nifedipine (10-6 
mol.l-1) and verapamil (10-5 mol.l-1), two L-type channel blockers 
(Kochegarov 2003), exhibited a significant inhibition of the GEA 3162 
action (Figures 3.6 and 3.7, Table 3.1). 
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Figure 3.6: The original recording (top) demonstrates the inhibition of the 
GEA 3162 (10-4 mol.l-1)-induced increase in the fura-2 ratio by nifedipine (10-6 
mol.l-1) at cultured myenteric ganglia of rat. The bar diagram shows the 
quantification of fura-2 fluorescence present in the myenteric plexus; for 
statistics, see Table 3.1. Results express means ± S.E.M. n = 52. Viability of 
cells was tested by the SERCA-blocker, cyclopiazonic acid (5.10-5 mol.l-1). 
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Figure 3.7: The original record (top) shows an inhibition in the GEA 3162  
(10-4 mol.l-1)-induced increase of the fura-2 ratio by verapamil (10-5 mol.l-1). 
The bars are showing the quantification of fura-2 fluorescence present in the 
myenteric plexus; for statistics, see Table 3.1. Results express means ± S.E.M., 
n = 38. Viability of cells was tested by the SERCA-blocker, cyclopiazonic acid 
(5.10-5 mol.l-1). 
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In contrast, after the exposure to a N-type blocker, ω-conotoxin GVIA 
(10-6 mol.l-1), only a partial reduction was observed (Figure 3.8). 
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Figure 3.8: Original record representing the partially inhibition of the response 
to GEA 3162 (10-4 mol.l-1) after addition of ω-conotoxin GVIA (10-6 mol.l-1) at 
rat cultured myenteric ganglia (top). The grafic demonstrates the quantification 
of the fura-2 fluorescence present in the myenteric plexus (bottom). For 
statistics, see text. Results are means ± S.E.M., n = 132. Viability of cells was 
tested by administration of the SERCA-blocker, cyclopiazonic acid (CPA;  
5.10-5 mol.l-1). 
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Finally, the ability of the P-type channel blocker, ω-agatoxin IVA (2.10-7 
mol.l-1), to interfer with the GEA 3162 response was tested. However, in 
the presence of this ’inhibitor’, a paradox potentiation of the effect of the 
NO donor was observed, as GEA 3162 evoked an increase in the fura-2 
ratio from 0.45 ± 0.02 to 0.63 ± 0.03 (Figure 3.9, Table 3.1). 
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Figure 3.9: Original record representing the paradox potentiation of the GEA 
3162 (10-4 mol.l-1)-induced increase in the fura-2 ratio after addition of ω-
agatoxin IVA (2.10-7 mol.l-1) in rat cultured myenteric ganglia (top). The 
graphic gives the quantification of fura-2 fluorescence present in the myenteric 
plexus (bottom), for statistics, see text. Results express means ± S.E.M (n = 
132), * p < 0.05 versus fura-2 ratio just prior administration of GEA 3162. 
Viability of cells was tested by administration of the SERCA-blocker, 
cyclopiazonic acid (CPA; 5.10-5 mol.l-1). 
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Table 3.1: Effects of inhibitors on the fura-2 fluorescence ratio in rat 
myenteric neurones  
 
 
Inhibitor Fura-2 ratio  
before GEA 
3162 
Fura-2 ratio 
after GEA 
3162 
Δ Fura-2 ratio n 
None 0.43 ± 0.013 0.51 ± 0.018* 0.077 ± 0.013a 66 
Ca2+-free 0.23 ± 0.006 0.24 ± 0.007 0.009 ± 0.001b 66 
Ni2+ 0.17 ± 0.010 0.18 ± 0.013 0.010 ± 0.004b 16 
Co2+ 0.20 ± 0.010 0.24 ±0.013 0.042 ± 0.005a,b 34 
Nifedipine 0.39 ± 0.018 0.40 ± 0.018 0.016 ± 0.001b 52 
Verapamil 0.46 ± 0.013 0.48 ± 0.014 0.019 ± 0.002b 38 
ω-Conotoxin 
GVIA 
0.55 ± 0.015 0.57 ± 0.015 0.014 ± 0.003b 132 
ω-Agatoxin IVA 0.43 ± 0.026 0.64 ± 0.035* 0.209 ± 0.023c 53 
 
Fura-2 ratio before and after administration of GEA 3162 (10-4 mol.l-1), 
and difference between both (Δ fura-2 ratio) in the absence of any 
inhibitors, in the absence of extracellular Ca2+, and in the presence of Ni2+ 
(10-3 mol.l-1), Co2+ (5.10-4 mol.l-1), nifedipine (10-6 mol.l-1), verapamil (10-5 
mol.l-1), ω-conotoxin GVIA (10-6 mol.l-1), or ω-agatoxin IVA (10-7  
mol.l-1). Values are means ± SEM, n = number of cells tested. * p < 0.05 
versus baseline before administration of GEA 3162. For the Δ fura-2 data, 
homogenous groups are indicated by identical letters (analysis of 
variances followed by test of Scheffé). 
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3.4. Identification of NOS expression in cultured myenteric ganglia 
by RT-PCR 
If NO should exert effects on myenteric ganglia under physiological 
conditions, the ganglionic cells should possess the ability to produce 
this gaseous messenger substance. Therefore, the expression of 
different subtypes of the NO synthase (NOS), the enzyme responsible 
for the production of NO from the amino acid arginine (Moncada et al. 
1989), was investigated using RT-PCR. Three different isoforms of NOS 
are known, i.e. nNOS, eNOS and iNOS (Xie et al. 1992, Michel and 
Lamas 1992, Huber et al. 1998). 
Specific primers for all subtypes were used (Schricker et al. 1996). 
GAPDH was used as internal standard to test the quality of the PCR 
reaction. cDNA from rat kindey, which expresses all three isoforms of 
NOS (Schricker et al. 1996), was used as reference tissue. 
Under basal conditions, both the mRNA for nNOS (Figure 3.10) as well 
as for eNOS (Figure 3.11) was found, although the latter only revealed a 
small, but highly reproducible band in the individual gels. Under basal 
conditions, iNOS expression could not be detected (data not shown). 
 
 73
1.5 mM Mg 2.5mM Mg 3.5 mM Mg
 
 
Figure 3.10: Representative gel electrophoresis image after RT-PCR for 
neuronal nitric oxide synthase (nNOS = bNOS) and GAPDH in cultured 
myenteric ganglia of rat (Neu.). Rat kidney (Kid.) served as control, Lad. = 
ladder ranging from 1000 to 50 bp. The nNOS primer yielded product of 
approximately 600 bp. Typical result from 3 independent experiments. 
 
 
Figure 3.11: Representative gel electrophoresis image after RT-PCR for 
endothelial nitric oxide synthase (eNOS) and GAPDH in cultured myenteric 
ganglia of rat. Rat kidney (Kid.) served as control, Lad. = ladder ranging from 
1000 to 50 bp. The eNOS primer yielded a product of approximately 200 bp. 
Typical result from 3 independent experiments.  
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iNOS has been proposed to be responsible for the production of NO 
during inflammatory reactions, because iNOS expression is induced by 
proinflammatory cytokines in many tissues (Wang and Marsden 1995). 
Therefore, in the next series of experiments, myenteric ganglia were 
pretreated for different time intervals with the proinflammatory cytokine, 
tumor necrosis factor-α (TNF-α). However, even after preexposure to 
TNF-α (100 ng.ml-1) for 4 h, 1 d or 3 d, no mRNA for iNOS was found in 
the myenteric ganglia (Figure 3.12). 
 
In the last experiment I tried using the whole tissue (longitudinal muscle 
layer-myenteric plexus preparation) of colon of adult rat after one day 
incubation with TNF-α to detect the mRNA of iNOS isoform, but cDNA 
obtained could not be amplified (data not shown). 
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Figure 3.12: Representative gel electrophoresis image after RT-PCR for 
inducible nitric oxide synthase (iNOS) and GAPDH in cultured myenteric 
ganglia of rat (Kid.= Kidney, Neu.= Neuron). Rat kidney served as control. 
Arrow: basal mRNA expression of iNOS in the control probe kidney. Lad. = 
ladder ranging from 1000 to 50 bp. The iNOS primer yielded product of 
approximately 200 bp. Typical result from 3 independent experiments. 
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3.5. Immunohistochemistry staining 
 
Immunohistochemical staining was used in order to localize NOS 
isoforms protein in the cultured myenteric ganglionic cells. 
Immunohistochemical studies revealed, consistent with the expression 
of the PCR product, the presence of both neuronal and endothelial NOS 
isoforms (Figure 3.13 and 3.14). 
A basal expression of iNOS was not found (data not shown). However, 
in contrast to the PCR experiments, an immunohistochemical signal for 
iNOS was detected after pretreatment of the ganglia with TNF-α (Figure 
3.15). 
As can be seen from the overlay with the nuclear marker, DAPI, which 
stains the nuclei of all cells in the preparation, not all ganglionic cells 
were immunoreactive for the respective enzyme. 
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Figure 3.13: Photomicrograph of nNOS immunoreactivity in rat cultured 
myenteric cells. A) nNOS immunoreactivity (red); B) Overlay of the nNOS 
signal (red) and nuclear marker DAPI (blue). Scale bars = 50 µm. 
A B
 
Figure 3.14: Expression of eNOS by immunohistochemistry at rat myenteric 
cells. A) eNOS immunoreactivity (red); B) Overlay of the eNOS signal (red) 
and the nuclear marker DAPI (blue). Scale bars = 50 µm. 
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Figure 3.15: Immunoreactivity of iNOS at rat myenteric ganglia after 
pretreatment with TNF-α. A) iNOS immunoreactivity (red); B) overlay of the 
iNOS signal and the nuclear marker DAPI (blue). Scale bars = 50 µm. 
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In order to answer the question, whether neurons or glia cells or both 
express nNOS and eNOS, double labelling experiments were 
performed. Neurons were labelled with the neuronal marker, PGP 9.5; 
glial cells were marked with GFAP. These experiments were only 
performed for the two NOS isoforms expressed under basal conditions, 
i.e. nNOS and eNOS. 
These experiments revealed that both PGP 9.5- as well as GFAP-
positive cells expressed both isoforms of NOS (Figure 3.16 and 3.17). 
 
 
 
Figure 3.16: Immunoreactivity of the glial marker, glial fibrillary acidic 
protein (GFAP, green), and colocalization with NOS1 and NOS3 (red) 
immunoreactivity at rat myenteric plexus. Arrows point at double-labelled 
cells. Scale bars = 20µm 
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Figure 3.17: Immunoreactivity of the neuronal marker, protein gene product 
9.5 (PGP 9.5; green), with NOS1 and NOS3 (red) immunoreactivity at rat 
myenteric plexus. Arrows point at double-labelled cells. Scale bars = 20µm 
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4.Discussion 
 
4.1. Action of NO on intracellular Ca2+ concentration of rat 
myenteric ganglia 
The aim of this study was to characterize the effect of the 
nonadrenergic-noncholinergic neurotransmitter, NO, on rat myenteric 
ganglia. Administration of the lipophilic NO donor, GEA 3162 (10-4  
mol.l-1), evoked a pronounced increase in the intracellular Ca2+ 
concentration mesaured at ganglia loaded with the Ca2+-sensitive 
fluorescent dye, fura-2 (Figure 3.1). 
Despite the heterogenity of enteric neurons concerning morphology, 
transmitter expression, or electrophysiological properties, the response 
was consistently observed at the cultured myenteric ganglia, suggesting 
that most of these cells respond to this neurotransmitter. As already 
mentioned in the Introduction, myenteric neurons have been classified 
according to several criteria, e.g. according to shape as Dogiel type Ι 
and type ΙΙ neurons, according to electrophysioloical properties as AH 
and S neurons, and according to function as sensory neurons, 
interneurons and motor neurons with different neurotransmitter 
expression (Wood 1994). Although the contribution of Ca2+ ions to the 
generation of action potential in AH-type neurons is pivotal, Ca2+ 
imaging studies have shown the presence of voltage-operated Ca2+ 
channels also in S-type neurons (Hanani and Ross 1997). 
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The increase in the cytosolic Ca2+ concentration caused by the NO 
donor was strongly reduced in the abscence of extracellular Ca2+ 
indicating the activation of Ca2+ influx from the extracellular space after 
exposure to NO (Figure 3.3). Neurons like many other cells use both 
extracellular and intracellular sources of calcium. The entry of Ca2+ from 
outside is regulated by voltage-operated channels or by receptor-
operated channels controlled by ionotropic neurotransmitters (Berridge 
1998). However, the voltage-operated channels constitute the main 
source of calcium in excitable cells such as neurons and muscle cells 
(Berridge et al. 1998). 
This finding was confirmed by the inhibition of the induced Ca2+ signal 
after addition of typical blockers of voltage-gated Ca2+ channels such as 
nifedipine, suggesting that the action of NO on cytosolic Ca2+ of 
myenteric ganglia is through this type of Ca2+ channels. 
 
4.2. Mechanism of action of Ca2+ channel blockers 
Calcium channel blockers (or antagonists), which I used as tools, refer 
to a chemically, pharmacologically and therapeutically heterogeneous 
group of drugs used either e.g. as cardiovascular therapeutic agents or 
as molecular tools (Triggle 2007). Nifedipine is the prototype of the 
dihydropyridine group. It contains in its molecular structure one 
dihydropyridine and one benzene cycle (Figure 4.1). Verapamil, 
belonging to the phenylalkylamines, consists of two benzene cycles 
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connected by a carbohydrate chain with one nitrogen atom (Figure 4.2). 
The mechanism, by which calcium channel blockers function, has been 
proposed to be via binding in the pore of the channels and initiating 
conformational changes rendering the channel non-conducting. Thereby 
they slow down recovery of calcium channels fom voltage-induced 
inactivation (Kochegarvo 2003). Sanguinetti and Kass (1984) suggested 
that verapamil reaches the Ca2+ channels from the cytoplasm, whereas 
nifedipine acts at an extracellular side and preferentially binds to the 
channel in the inactivated state. Verapamil and nifedipine are 
traditionally used for treatment of cardiovascular diseases, e.g. as 
vasodilators in hypertension acting through relaxation of smooth muscle 
of blood vessels and reduction in blood pressure. They are also used in 
other disorders such as angina pectoris and arrythmia (Epstein 2002). 
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Figure 4.1: Structure of nifedipine. From Wikipedia.org 
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Figure 4.2: Structure of verapamil. From Wikipedia.org 
 
 
 
The toxin peptides ω-conotoxin GVIA and ω-agatoxin IVA have been 
isolated from the venom of the snail Conus geographus and the funnel 
web spider Agelenopsis aperta, respectively. These animals use these 
toxins to paralyze their victims (Jones et al. 2001, McDonough et al. 
2002). Conotoxins act by inhibiting presynaptic N-type calcium channels 
thereby preventing neurotransmitter release. They are useful tools for 
the block and for the study of synaptic transmission. In contrast, SNX-
111 is a synthetic analog of ω-conotoxin MVΙΙA. It was developed for 
treatment of acute pain. These toxin peptides are structurally composed 
of amino acid residues that have short sites as short as dipeptide 
responsible for binding and blockade of calcium channels (Kochegarvo 
2003; Figure 4.3). ω-agatoxin IVA has been found to be a potent blocker 
of P-type calcium channels in cerebellar Purkinje neurons which are 
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insensitive to both dihydropyridines and ω-conotoxin GVIA and since 
has been termed P-type calcium current blocker (Noony et al. 1997). 
 
 
Cys-Lys-Ser-Hyp-Gly-Ser-Ser-Cys-Ser-Hyp-
Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-
        Hyp-Tyr-Thr-Lys-Arg-Cys-Tyr-NH2  
 
Figure 4.3: The peptide calcium channel blocker ω-conotoxin GVIA. From 
www.tocris.com/dispprod.php 
 
 
The mechanism of Ca2+ channel blockade by the divalent cations Ni2+ 
and Co2+ has been shown to be throughout the competition with the 
permeating ion, Ca2+. This process seems to take place within the 
channel itself, because these cations have a high affinity to divalent 
cation binding site, i.e. they stick in the pore of the channel and block 
permeation by other ions (Pelzer et al. 1990). The divalent cations Ni2+ 
and Co2+ are non-specific blockers of calcium channels, however, a 
high sensitivity of R-currents, which are resistant to other known Ca2+ 
channel blockers, has been shown (Noony et al. 1997, Bian et al. 2004). 
 
My results concerning the action of NO on cytosolic Ca2+ in myenteric 
ganglia conflict with data from previous studies at other tissues, as in 
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bovine chromaffin cells (Carabelli et al. 2002), in rat cardiac cells (Hu et 
al. 1997), in rat dorsal root ganglion neurons (Yoshimura et al. 2001) 
and in rat cortical neurons (Petzold et al. 2005) it was reported that NO 
inhibits the activities of voltage-gated Ca2+ channels. However, in 
agreement with my findings, studies in rat sympathetic neurons (Chen 
and Schofield 1995) or in retinal ganglion cells (Hirooka et al. 2000) 
revealed that NO activates these channels. The discrepancy between 
these studies is difficult to explain and could attribute to the different 
types and concentrations of NO donors used, the cell types studied and 
different experimental procedures (Petzold et al. 2005). Another 
explanation might contribute to the controversial effect of NO on 
voltage-gated Ca2+ channels: NO may affect the channel activity by 
different mechanisms, since a direct effect by S-nitrosylation and an 
indirect effect by guanylate cyclase pathway have been suggested 
(Campbell et al. 1996). This hypothesis is supported by the observation 
that NO directly activates P/Q type Ca2+ channels (Chen et al. 2002), 
whereas the NO-induced production of cGMP inhibits these channels 
(Grassi et al. 1999). 
The data obtained in the present study demonstrate that L-type Ca2+ 
channels are the major pathway for the NO effect on Ca2+ entry in rat 
myenteric ganglia, because the two L-type Ca2+ channels blockers 
tested, nifedipine and verapamil, had a strong inhibitory action on the 
stimulation of the Ca2+ influx induced by the NO donor. This finding is 
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supported by earlier pharmacological studies at rat myenteric ganglia 
showing that L- and N-type Ca2+ channels seem to be the most 
important Ca2+ influx pathways at these cells (Schäufele and Diener 
2005). However, Bian et al. (2004) obtained evidence that R-type Ca2+ 
channels make the largest contribution to the total Ca2+ current in 
myenteric neurons of guinea pig small intestine which may reflect 
species-differences in neuronal Ca2+ channel expression. 
The paradox effect of ω-agatoxin on P-type Ca2+ current (Figure 3.9) on 
rat myenteric ganglia is difficult to explain. The P-type Ca2+ current is 
well known from other nervous tissues to be sensitive to ω-agatoxin. For 
example, Zaitsev et al. (2007) and Santiago et al. (2008) reported that 
this blocker significantly inhibited the Ca2+ current mediated by P-type 
Ca2+ channels in rat brain neurons. An explanation for this conflicting 
result has been described to be due to the insensitivity of P-type current 
in some enzymatically dissociated neurons to typical Ca2+ blockers 
(Regan 1991, Mintz et al. 1992, Tringham et al. 2008). However, in 
previous experiments in our laboratory at rat myenteric ganglia using 
the same approach as used in this study, an inhibitory effect of the ω-
agatoxin blocker on P-type Ca2+ current has been shown (Schäufele 
and Diener 2005). 
Further studies are needed to investigate the mechanism by which NO 
affects Ca2+ signalling in myenteric ganglia and to clarify whether Ca2+ 
influx through voltage-gated Ca2+ channels induced by NO is amplified 
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by Ca2+ release from the intracellular stores through the mechanism 
Ca2+-induced Ca2+ release via ryanodine and IP3 receptors. The inositol 
trisphosphate receptors (IP3Rs) and ryanodine receptors (RYRs) at the 
endoplasmic reticulum contribute to the Ca2+ signalling, as both are 
sensitive to Ca2+ entering from the extracellular space through either 
voltage-operated or receptor-operated Ca2+ channels. This calcium 
provides the “trigger Ca2+“ to stimulate Ca2+ release from the internal 
stores of the endoplasmic reticulum. This so-called Ca2+-induced Ca2+ 
release is often responsibe for amplifying Ca2+ signals coming from the 
outside (Miller 1991, Barish 1991). 
There is an interesting possibility of a positive feed-back loop between 
cytosolic Ca2+ and NO: Two isoforms of NO synthases (nNOS and 
eNOS) are Ca2+-dependent. Consequently, the increase in the cytosolic 
Ca2+ concentration induced by NO might induce a further stimulation of 
NO production as already suggested for some other cells (Publicover et 
al. 1993, Moncada et al. 1991). 
 
4.3. Functional role of NO in the myenteric plexus 
An inhibitory role of nitric oxide on enteric neurons has been identified. 
Yuan and his coworkers (1995) found that NO plays a role in retrograde 
transmission between interneurons and sensory neurons as NO 
released from descending interneurons, which are involved in the 
descending pathway of the peristaltic reflex, acts back on the sensory 
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neurons to inhibit neurotransmission. Therefore, they concluded that NO 
can modulate intestinal motor reflexes via an action on neurons. 
Moreover, it has been reported that NO suppresses noncholinergic slow 
excitatory postsynaptic potentials by suppression of the release of 
neurotransmitters presynaptically at the slow excitatory synapses in 
myenteric neurons of guinea pig small intestine (Tamura et al. 1993). In 
addition, the presence of NOS immunoreactivity both in the cell bodies 
and in the nerve terminals that make synaptic contacts with other 
myenteric neurons indicated a possible role of NO as an ortho- or a 
retrograde neurotransmitter within the myenteric plexus (Bredt et al. 
1990). 
Given the inhibitory action of nitric oxide on myenteric neurons, a finding 
has come from our laboratory using the patch clamp technique to 
examine NO action on cell membrane potential of myenteric neurons 
indicating that NO hyperpolarizes the cell membrane. This 
hyperpolarization is related to activation of Ca2+-dependent K+ channels 
(Sitmo et al. 2007). The effect of NO on membrane potential was 
inhibited after blockade of K+ channels by Cs+. Thus, this observation 
might explain the inhibitory effect of NO on cell excitability of myenteric 
neurons. 
We can conclude from the forementioned data that the nonadrenergic 
noncholinergic neurotransmitter nitric oxide affects myenteric ganglia by 
stimulation of voltage-dependent Ca2+ channels, predominantly of the 
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L-type. This causes the opening of Ca2+-dependent K+ channels and a 
hyperpolarization of the cell membrane. 
If myenteric ganglia are exposed to NO released from nonneural 
sources, as from immune inflammatory cells in the gastrointestinal tract 
during inflammatory conditions, and if the principle action is expected to 
be suppression of cell excitability postsynaptically or an inhibition of 
slow synaptic excitation at presynaptic site, the question arises, what is 
the pathophysiological relevance of this action of NO? 
NO has been identified to be one of the neuromodulators released in a 
paracrine fashion in inflammatory states by immune cells such as mast 
cells. Electrophysiological studies on enteric neurons confirm that these 
inflammatory mediators alter the electrical and synaptic behavior of 
enteric neurons. For example, the release of histamine and serotonin 
from mast cells in response to invading organisms affects the neural 
elements of the enteric nervous system, which respond by running a 
defense program designed to eliminate the antigens from the lumen. 
Copious secretion and increased blood flow followed by orthograde 
power motor propulsion of the luminal contents are the output of the 
neural program (Wood 2004). Nitric oxide has been defined to have an 
inhibitory action on enteric neurons and intestinal musculature. The role 
of NO in inflammatory states is still unknown. However, it has been 
shown that NO inhibits norepinephrine release from myenteric neurons 
thereby removing the sympathetic inhibition of secretomotor neurons, 
 91
which might contribute to secretory diarrhoea during inflammation (Rühl 
and Collins 1997). In general, the inflammatory process in the bowl is 
complex and does not function through a single pathway and the 
mechanism of inflammation and repair may require many, all, or none of 
the NO responses (Valentine et al. 1996). 
 
4.4. Nitric oxide synthases in the myenteric plexus 
The second object of the present study was to determine the expression 
of NOS isoforms, i.e. the forms of the enzyme responsible for NO 
production under physiological and pathophysiological conditions. 
Assessment of nNOS and eNOS by RT-PCR and 
immunohistochemistry revealed the presence of both enzymes in 
myenteric ganglia under basal conditions (Figures. 3.10, 3.11, 3.13, 
3.14), whereas the inducible NOS (iNOS) could only be shown by 
immunohistochemistry assay and only after pretreatment with the 
proinflammatory cytokine, TNF-α (Figures. 3.12; 3.15). Tumor necrosis 
factor-α (TNF-α) is a proinflammatory cytokine produced by many cell 
types including macrophages, monocytes or lymphocytes in response to 
infection, inflammation and other environmental challenges. The 
molecular mechanism by which TNF-α mediates cellular responses is 
thought to be through binding to its two receptors, TNFR1 and TNFR2. 
This binding leads to activation of distinct effectors which, in turn, leads 
to activation of nuclear transcription factors such as AP-1 and NF-κB, 
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that induce genes involved in inflammatory responses (Baud and Karin 
2001). 
NF-κB has been shown to be related to the activation of the inducible 
form of nitric oxide synthase (iNOS). NF-κB under basal conditions is 
sequestered in the cytoplasm as an inactive complex bound to its 
inhibitor protein IκB. A variety of different stimuli, including bacterial 
products, inflammatory cytokines, and oxidants activate this 
transcription factor. Once activated, NF-κB translocates to the nucleus 
of the cell where it binds to different agents and activates the 
transcription of genes known to be important in the immune and 
inflammatory response including the regulation of the transcription of the 
enzyme iNOS. Thus, the production of NO increases in inflammatory 
states (Pavlick et al. 2002). 
In contrast to the immunohistochemical experiments, I was not able to 
identify the mRNA for iNOS, even after pretreatment with TNF-α (Figure 
3.12). The most plausible explanation for this failure is the different life 
time of mRNA and cellular proteins. In other words, the “time windows” 
after administration of TNF-α, in which I looked for this mRNA, was not 
adequate to register the expected transient upregulation of iNOS 
mRNA, which should preceed the increase in the expression of the 
iNOS protein. 
The inducible NOS is believed to represent the major source of NO in 
inflammatory bowel disease (Kimura et al. 1998). It was found to be 
 93
expressed in response to inflammatory cytokines such as IL-1β and 
bacterial products (e.g. lipopolysaccharides) by immune cells such as 
macrophages and neutrophils and by myenteric neurons (Xie et al. 
1992, Valentine et al. 1996). Overproduction of NO during intestinal 
inflammation has been identified (Lundberg et al. 1994, Cross and 
Wilson 2003). However, studies examining the role of NO in 
inflammatory states of the gut have revealed conflicting results and the 
mechanism by which iNOS exerts its effects remains unclear (Vallance 
et al. 2004). iNOS production by macrophages and other phagocytes is 
thought to primarily act as an antimicrobial mechanism that helps to 
destroy bacteria. However, the excess of reactive oxygene species 
(ROS) produced by activated immune cells and myenteric cells after 
exposure to cytokines under inflammatory conditions and the induction 
of NO production via iNOS may provide a neuroprotective role by 
scavenging the excess oxygen radicals by a mechanism thought to be 
mediated through the reaction with superoxide anions (O2-) to generate 
peroxynitrite (Beckmann et al. 1990), which may contribute to intestinal 
damage in gut inflammation. 
iNOS immunoreactivity was observed also in most ganglionic cells 
(Figure 3.15) sugessting that also the glial cells, which constitute about 
half of the ganglionic cells, respond to the proinflammatory cytokine 
TNF-α by producing NO. An evidence supports this finding in a dextran 
sodium sulfate-induced colitis model, where iNOS glial immunoreactivity 
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has been found. The authors imply a role for these cells in the 
modulation of epithelial Cl− transport (Green et al. 2004). 
The presence of nNOS and eNOS in the myenteric plexus has been 
demonstrated by other studies (Bredt et al. 1990, Aimi et al. 1993). 
However, immunohistochemical studies in guinea-pig gastrointestinal 
tract have shown that NOS is found in inhibitory motor neurons 
innervating circular muscle and in descending interneurons, but not in 
cells that have been identified electrophysiologically as sensory neurons 
(Yuan et al. 1995). These enzymes are activated only during periods of 
activation in normal physiological responses when cytoplasmic Ca2+ 
concentration rises and the NO released by them acts as a transduction 
mechanism underlying physiological response (Sanders and Ward 
1992). For example, NO released by eNOS in endothelial cells in 
response to stimulation by acetylcholine acts to relax blood vessels and 
to increase the blood flow to the tissues. Nitric oxide released by nNOS 
in response to nerve stimulation of the myenteric plexus causes 
relaxation of the gastrointestinal smooth muscles, which plays an 
important physiological role in various parts of the gastrointestinal tract. 
Nitric oxide regulates e.g. the muscle tone of the sphincter in the lower 
esophagus, the pylorus and the anus and regulates the accomodation 
reflex of the stomach and the peristaltic reflex of the intestine 
(Takahashi 2003). However, recent reports have shown eNOS and 
nNOS to be also of pathophysiological significance. Synthesis of NO in 
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myenteric neurons by nNOS during early experimental endotoxemia has 
been suggested to be involved in stomach hypocontractility and 
hypothesized to maxime the neural activity bevor the recruitment of 
immune response through iNOS (Quintana et al. 2004). Vallance and 
coworkers (2004) reported in experimental colitis that the eNOS isoform 
plays a role for mucosal integrity, because eNOS knockout mice 
developed severe colitis with fewer goblet cells compared with wild-type 
animals. 
Glial cells showed bNOS as well as eNOS immunoreactivity under basal 
conditions (Figure 3.16), demonstrating that these cells may well affect 
neighbouring neurons via NO. 
 
In summary, my results demonstrate that NO, which can be 
physiologically produced within myenteric neurons, affects excitability of 
the myenteric neurons via a stimulation of voltage-dependent Ca2+ 
channels. 
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5. Summary 
 
In this work I investigated the myenteric plexus of the rat small intestine with 
regard to the effects of the nonadrenergic-noncholinergic neurotransmitter, 
nitric oxide (NO). The action of NO on the intracellular calcium concentration 
[Ca2+]i of myenteric ganglionic cells was measured with imaging experiments; 
the presence of the enzyme responsible for synthesis of NO, i.e. the nitric 
oxide synthases, was investigated with polymerase chain reaction and 
immunohistochemical experiments. 
Myenteric ganglia from 5 - 12 days old rats were enzymatically isolated and 
kept for about 15 h under cell culture conditions. Changes in [Ca2+]i were 
measured by loading the ganglia with the Ca2+-indicator fluorescence dye, 
fura-2, and exposure to the NO donor, GEA 3162 (10-4 mol.l-1). The NO donor 
induced a pronounced increase in [Ca2+]i. This increase was reduced in the 
absence of extracellular Ca2+ and after exposure to blockers of voltage-
operated Ca2+ channels, indicating that the effect of NO on [Ca2+]i is via 
activation of this type of Ca2+ channels. L- and N-type Ca2+ channels seem to 
play the dominant role by which NO induces changes in [Ca2+]i, since the 
blockers nifedipine and ω-conotoxin caused the most effective inhibition in 
fura-ratio signal evoked by NO. 
PCR and immunohistochemical experiments revealed the presence of both 
neuronal and endothelial nitric oxide synthase isoforms in myenteric cells. The 
inducible isoform was shown by immunohistochemical experiments after 
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incubation of the cells with the proinflammatory cytokine, TNF-α, indicating 
that NO is physiologically produced within myenteric ganglia. 
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6. Zusammenfassung 
 
Im Rahmen dieser Arbeit wurde die Wirkung des nonadrenergen-
noncholinergen Neurotransmitters Stickstoffmonooxid (NO) auf Zellen 
des Plexus myentericus der Ratte untersucht inklusive der Expression 
der Enzyme, die für die Produktion dieses Neurotransmitter 
verantwortlich sind. 
Myenterische Ganglien von 5 bis 12 Tage alten Ratten wurden 
enzymatisch isoliert und nach ca. 15 Stunden in Kultur mit dem Ca2+-
Indikator Fura-2-AM beladen. Die intrazelluläre Ca2+-Konzentration 
([Ca2+]i) wurde mit der Imaging Methode gemessen. 
Imaging Experimente zeigten, dass der NO Donor GEA 3162 (10-4  
mol.l-1) einen signifikanten Anstieg der intrazellulären 
Calciumkonzentration verursachte. Dieser Anstieg ist durch Aktivierung 
spannungsabhängiger Ca2+-Kanäle verursacht, da der NO-Effekt in 
Abwesenheit von extrazellulärem Ca2+ oder nach Zugabe von Blockern 
von spannungsabhängigen Ca2+-Kanälen stark gehemmt war.  
Der Einfluss von GEA 3162 auf myenterische Zellen der Ratte scheint 
durch L- und N-Typ spannungsabhängige Ca2+-Kanäle vermittelt zu 
sein, denn die Hemmstoffe dieser Ca2+-Kanäle, Nifedipin bzw. ω-
Conotoxin, erwiesen sich als die wirksamsten, um den NO-bedingten 
Anstieg von ([Ca2+]i) zu vermindern. 
Polymerasekettenreaktions- (PCR-) und immunhistochemische 
Versuche wiesen die Existenz mehrerer Isoformen des Enzyms NO 
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Synthase, nämlich der neuronalen Form (nNOS) und der endothelialen 
Form (eNOS), nach. Die dritte Isoform, die induzierbare NOS (iNOS), 
konnte nur mit immunhistochemischen Versuchen nach Stimulation der 
Ganglien mit dem proinflammatorischen Zytokin TNF-α nachgewiesen 
werden. Diese Versuche zeigen, dass NO unter physiologischen 
Bedingungen im Plexus myentericus gebildet werden kann. 
 100
7. References 
Aimi Y, Kimura H, Kinoshita T, Minami Y, Fujimura M, Vincent SR. 
Histochemical localization of nitric oxide synthase in rat enteric nervous 
system. Neuroscience 53: 553-56, 1993 
Altdorfer K, Bagam'eri G, Donath T, Feher E. Nitric oxide synthase 
immunoreactivity of interstitial cells of Cajal in experimental colitis. Inflamm 
Res 51: 569-571, 2002 
Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates 
guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate 
levels in various tissue preparations. Proc Natl Acad Sci USA 74: 3203-
3207, 1977  
Barish ME. Increases in intracellular calcium ion concentration during 
depolarization of cultured embryonic Xenopus spinal neurons. J Physiol 
444: 545-565, 1991 
Baud V, Karin M. Signal transduction by tumor necrosis factor and its 
relatives. Trends Cell Biol 11: 372-377, 2001 
Bayliss WM, Starling EH. The movements and innervation of the small 
intestine. J Physiol 24: 100-143, 1899 
Baylor SM, Hollingworth S. Measurement and interpretation of 
cytoplasmic [Ca2+] signals from calcium-indicator dyes. News Physiol Sci 
15: 19-26, 2000 
Bean BP. Classes of calcium channels in vertebrate cells. Annu Rev 
Physiol 51: 367-384, 1989 
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. 
Apparent hydroxyl radical production by peroxynitrite: implications for 
endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci 
USA 87: 1620-1624, 1990 
Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: 
the good, the bad, and ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 
1996 
Berghe PV, Missiaen L, Janssens J, Tack J. Calcium signalling and 
removal mechanisms in myenteric neurones. Neurogastroenterol Mot 14: 
63-73, 2002 
Berridge MJ, Bootman MD, Lipp P. Calcium a life and death signal. 
Nature 395: 645-648, 1998 
 101
Berridge MJ. Neuronal calcium signaling. Neuron 21: 13-26, 1998 
Berthoud HR, Jedrzejewska A, Powley TL. Simultaneous labeling of 
vagal innervation of the gut and afferent projections from the visceral 
forebrain with Dil injected into the dorsal vagal complex in the rat. J Comp 
Neurol 301: 65-79, 1990 
Berthoud HR, Kressel M, Raybould HE, Neuhuber WL. Vagal sensors in 
the rat duodenal mucosa: distribution and structure as revealed by in vivo 
Dil-tracing. Anat Embryol 191: 203-212, 1995 
Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the 
afferent vagal system. Auton Neurosci Basic Clin 85: 1-17, 2000  
Berthoud HR, Powley TL. Vagal afferent innervation of the rat fundic 
stomach: morphological characterization of the gastric tension receptor. J 
Comp Neurol 319: 261-276, 1992 
Bian X, Zhou X, Galligan JJ. R-type calcium channels in myenteric 
neurons of guinea pig small intestine. Am J Physiol Gastrointest Liver 
Physiol 287: G134-G142, 2004 
Bodian M, Stephens FD, Ward BCH. Hirschsprung’s disease and 
idiopathic megacolon. Lancet 1: 6-11, 1949 
Bornstein JC, Costa M, Furness JB, Lees GM. Electrophysiology and 
Enkaphalin immunoreactivity of identified myenteric plexus neurons of 
guinea-pig small intestine. J Physiol 351: 313-325, 1984 
Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase 
indicating a neural role for nitric oxide. Nature 347: 768-770, 1990 
Busse R, Mulsch. Calcium-dependent nitric oxide synthesis in endothelial 
cytosol is mediated by calmodulin. FEBS Lett 265: 133-136, 1990 
Calignano A, Whittle JR, Di Rosa M, Moncada S. Involvement of 
endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur 
J Pharmacol 229: 273-276, 1992 
Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type 
calcium channels in ferret ventricular myocytes: Dual mechanism 
regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108: 277-
293, 1996 
Carabelli V, Ascenzo MD, Carbone E, Grassi C. Nitric oxide inhibits 
neuroendocrine Ca1 L-channel gating via cGMP-dependent protein kinase 
in cell-attached patches of bovine chromaffin cells. J Physiol 541: 351–366, 
2002 
 102
Cattell V, Jansen A. Inducible nitric oxide synthase in inflammation. 
Histochem J 27: 777-784, 1995 
Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. International 
union of pharmacology. XL. Compendium of voltage-gated ion channels: 
Calcium channels. Pharmacol Rev 55: 579-581, 2003 
Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. 
Annu Rev Cell Dev Biol 16: 521-555, 2000 
Chen C, Schofield GG. Nitric oxide donors enhanced Ca2+ currents and 
blocked noradrenaline-induced Ca2+ current inhibition in rat sympathetic 
neurons. J Physiol 482: 521–531, 1995 
Chen J, Daggett H, Waard Mde, Heinemann SH, Hoshi T. Nitric oxide 
augments voltage-gated P/Q-type Ca2+ channels constituting a putative 
positive feedback loop. Free Radical Biol Med 32: 638–649, 2002 
Clementi E. Role of nitric oxide and its intracellular signalling pathways in 
the control of Ca2+ homeostasis. Biochem Pharmacol 55: 713-718, 1998 
Costa M, Brookes SJH, Hennig GW. Anatomy and physiology of the 
enteric nervous system. Gut 47: 15-19, 2000 
Costa M, Furness JB, Llewellyn-Smith IJ, Cuello AC. Projections of 
substance P neurons within the guinea-pig small intestine. Neuroscience 6: 
411-424, 1986 
Costa M, Waterman S, Brookes SJH. The role of nitric oxide synthesizing 
enteric neurons in peristalsis in the guinea-pig small and large intestine 
(Abst.). Proc Aust Physiol Pharmacol Soc 22: 98, 1991 
Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. 
Inflamm Bowel Dis 9: 179-189, 2003 
Daniel EE, Jury J, Salapatek AM, Bowes T, Lom A, Thomas S, 
Ramnarain M, Nguyen V, Mistrv V. Nitric oxide from enteric nerves acts 
by a different mechanism from myogenic nitric oxide in canine lower 
esophageal sphincter. J Pharmacol Exp Ther 294: 270-279, 2000 
Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide 
synthase and neuronal NADPH diaphorase are identical in brain and 
peripheral tissues. Proc Natl Acad Sci USA 88: 7797-7801, 1991 
Derkach V, Surprenant A, North RA. 5-HT3 receptors are membrane ion 
channels. Nature 339: 706-709, 1989 
 103
Dogiel AS. Über den Bau der Ganglien in den Geflechten des Darmes und 
der Gallenblase des Menschen und der Säugetiere. Arch Anat Physiol 
Leipzig Anat Abt 130-158, 1899 
Drew GM. Pharmacological characterization of the presynaptic α-
adrenoceptors regulating cholinergic activity in the guinea-pig ileum. Br J 
Pharmacol 64: 293-300, 1978 
Epstein M. In: Epstein M, editor. Calcium antagonists in clinical medicine. 
3rd ed., philadelphia, PA: Hanley and Belfus, 2002  
Fox EA, Phillips RJ, Martinson FA, Baronowsky EA, and Powley TL. 
Vagal afferent innervation of smooth muscle in the stomach and duodenum 
of the mouse: morphology and topography. J Comp Neurol 428: 558-576, 
2000 
Furness JB, Costa M. The enteric nervous system. London/NewYork: 
Churchill Livingston, 1987 
Galione A. Cyclic ADP-ribose, the ADP-ribosyl cyclase pathway and 
calcium signaling. Mol Cell Endocrinol 98: 125-131, 1994 
Garg UC, Hassid A. Nitric oxide decreases cytosol free calcium an 
balb/c3T3 fibroblasts by a cyclic GMP-independt mechanism. J Biol Chem 
266: 9-12, 1991 
Garthwait J, Charles SL, Chess-Williams R. Endothelium derived 
relaxing factor release on activation of NMDA receptors suggests role as 
intercellular messenger in the brain. Nature 336: 385-388, 1988 
Gershon MD. The enteric nervous system. Ann Rev Neurosci 14: 227-272, 
1981 
Gonella J, Bouvier M, Blanquet F. Extrinsic nervous control of motility of 
small and large intestines and related sphincters. Physiol Rev 67: 902-961, 
1987 
Grafe P, Mayer CJ, Wood JD. Evidence that substance P does not 
mediate slow synaptic excitation within the myenteric plexus. Nature 279: 
720-721, 1979 
Grassi CD, Ascenzo M, Valente A, Battista Azzena G. Ca2+ channel 
inhibition induced by nitric oxide in rat insulinoma RINm5f cells. Pflugers 
Arch 437: 241-247, 1999 
Green CL, Ho W, Sharkey KA, McKay DM. Dextran sodium sulfate-
induced colitis reveals nicotinic modulation of ion transport via iNOS-
derived NO. Am J Physiol Gastrointest Liver Physiol 287: G706-G714, 
2004 
 104
Grider JR, Jin JG. Distinct populations of sensory neurons mediate the 
peristaltic reflex elicited by muscle stretch and mucosal stimulation. J 
Neurosience 14: 2854-2860, 1994 
Grundy D, Scratcherd T. Sensory afferents from the gastrointestinal tract. 
In: Wood JD, editor. Handbook of physiology, section 6, vol. 1, part 1. 
Bethesda, MD: American Physiological Society. p 593-620, 1989 
Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic 
afferent. Gut 51: 2-5, 2002 
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca+2 indicators 
with greatly improved fluorescence properties. J Biol Chem 260: 3440-
3450, 1985 
Hanani M, Lasser-Ross N. Activity-dependent changes in intracellular 
calcium in myenteric neurons. Am J Physiol Gastrointest Liver Physiol. 273: 
G1359-G1363, 1997 
Hendrisks R, Bornstein JC, Furness JB. An electrophysiological study of 
the projections of putative sensory neurons within the myenteric plexus of 
the guinea-pig ileum. Neurosci Lett 110: 286-290, 1990 
Hess DT, Matsumoto A, Kim SO, Marshal HE, Stamler JS. Protein S-
nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 6: 150-166, 
2005 
Hirooka K, Kourennyi DE, Barnes S. Calcium channel activation 
facilitated by nitric oxide in retinal ganglion cells. J Neurophysiol 83: 198-
206, 2000 
Hirst GDS, Holman ME, Spence I. Two types of neurones in the myenteric 
plexus of duodenum in the guinea-pig. J Physiol 236: 303:326, 1974 
Hofmann F, Biel M, Flockerzi V. Molecualr basis for Ca2+ channel 
diversity. Annu Rev Neurosci 17: 399-418, 1994 
Holst MC, Kelly JB, Powley TL. Vagal preganglionic projections to the 
enteric nervous system characterized with phaseolus vulgaris-
leucoagglutinin. J Comp Neurol 381: 81-100, 1997 
Hölzer HH, Raybould HE. Vagal and splanchnic sensory pathways 
mediate inhibition of gastric motility induced by duodenal distension. Am J 
Physiol 262: G603-608, 1992 
Horiguchi K, Sanders KM, Ward SM. Enteric motor neurons from 
synaptic-like junctions with interstitial cells of Cajal in the canine gastric 
antrum. Cell Tissue Res 311: 299-313, 2003 
 105
Hu H, Chiamvimonvat N, Yamagishi T, Marban E. Direct inhibition of 
expressed cardiac L-type Ca2+ channels by S-nitrosothiol nitric oxide 
donors. Circ Res 81: 742-752, 1997 
Huber A, Saur D, Kurjak M, Schusdziarra V, Allescher H. 
Characterization and splice variants of neuronal nitric oxide synthase in 
rat small intestine. Am J Physiol Gastrointest Liver Physiol 275: 1146-
1156, 1998 
Jacobowitz D. Histochemical studies of the autonomic innervation of the 
gut. J Pharmacol Exp Therap 149: 358-364, 1965 
Janson G, Martinson J. Studies on the ganglionic site of action of 
sympathetic outflow to the stomach. Acta Physiol Scand 68: 184-192, 1966 
Jiménez M, Borderies JR, Vergara P, Wang Y, Daniel EE. Slow waves in 
circular muscle of porcine ileum: structural and electrophysiological studies. 
Am J Physiol 276: G393-G406, 1999 
Johnson SM, Katayama Y, North RA. Slow synaptic potentials in 
neurones of the myenteric plexus. J Physiol 301: 505-516, 1980 
Jones RM, Cartier GE, Mcintosh JM, Bulaj G, Farrar VE, Olivera BM. 
Composition and therapeutic utility of conotoxins from genus Conus. Exp 
Opin Ther Patents 11: 603-623, 2001 
Katayama Y, North RA. Does substance P mediate slow synaptic 
excitation within the myenteric plexus? Nature 274: 387-388, 1978 
Kennedy MB. Regulation of neuronal function by calcium. Trends Neurosci 
12: 417-420, 1989 
Kerr FW, Preshaw RM. Secretomotor function of the dorsal motor nucleus 
of the vagus. J Physiol 205: 405-415, 1969 
Kilbinger H, Wolf D. Increase by NO synthase inhibitors of acetylcholine 
release from guinea-pig myenteric plexus. Naunyn-Schmiedeberg's Arch 
Pharmacol 349: 543-545, 1994 
Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, 
Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishiii H. 
Increased expression of inducible isoform of nitric oxide synthyse and 
the formation of peroxynitrite in colonic mucosa of patients with active 
ulcerative colitis. Gut 42: 180-187, 1998 
Kirchgessner AL, Gershon MD. Identification of vagal efferent fibers and 
putative target neurons in the enteric nervous system of the rat. J Comp 
Neurol 285: 38-53, 1989 
 106
Kirchgessner AL, Liu MT. Differential localization of Ca2+ channel alpha1 
subunits in the enteric nervous system: presence of alpha B channel-like 
immunoreactivity in intrinsic primary afferent neurons. J Comp Neurol 409: 
85-104, 1999 
Kochegarov AA. Pharmacological modulators of voltage-gated calcium 
channels and their therapeutical application. Cell Calcium 33: 145-162, 
2003 
Kuntz A, Saccomanno G. Reflex inhibition of intestinal motility mediated 
through decentralized prevertebral ganglia. J Neurophysiol 7: 163-170, 
1944 
Kunze WAA, Furness JB, Bertrand PP, Bornstein JC. Intracellular 
recording from myenteric neurons of the guinea-pig ileum that respond to 
stretch. J Physiol 506: 827-842, 1998 
Lang RJ, Harvey JR, McPhee GJ, Klemm MF. Nitric oxide and thiol 
reagent modulation of Ca2+-activated K+ channels in myocytes of the 
guinea-pig taenia caeci. J Physiol 525: 363-376, 2000 
Langley JN, Magnus R. Some observations of movements of the intestine 
before and after degenerative section of the mesenteric nerves. J Physiol 
33: 34-51, 1905 
Langley JN. Connexions of the enteric nerve cells. J Physiol 56: 39, 1922 
Larsson L. Immunocytochemistry: Theory and practice, CRC Press, Inc., 
Boca Raton, Florida, 1988 
Lundberg JON, Hellstrom PM, Lundberg JM, Alving K. Greatly 
increased luminal nitric oxide in ulcerative colitis. Lancet 344: 1673-
1674, 1994 
Lundgren O. Sympathetic input into the enteric nervous system. Gut 47: 
33-35, 2000 
Mancinelli R, Fabrizi A, Vargiu R, Morrone L, Bagetta G, Azzena GB. 
Functional role of inducible nitric oxide synthase on mouse colonic motility. 
Neurosci Lett 311: 101-104, 2001 
McDonough SI, Boland LM, Mintz IM, Bean BP. Interactions among 
toxins that inhibit N-type and P-type calcium channels. J Gen Physiol 119: 
313-328, 2002 
Mei N. Intestinal chemosensitivity. Physiol Rev 65: 221, 1985 
 107
Michel T, Lamas S. Molecular cloning of constitutive endothelial nitric 
oxide synthase: evidence for a family of related genes. J Cardiovasc 
Pharmacol 12: 45-49, 1992 
Miller RJ. The control of neuronal Ca2+ homeostasis. Prog Neurobiol 37: 
255-285, 1991 
Mintz IM, Adams ME, Bean BP. P-type calcium channels in rat central and 
peripheral neurons. Neuron 9: 85–95, 1992 
Moncada S, Palmer R MJ, Higgs EA. Biosynthesis of nitric oxide from 
L-arginine, a pathway for the regulation of cell function and 
communication. Biochem Pharmacol 38: 1709-1715, 1989 
Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, 
pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991 
Moncoq K, Trieber CA, Young HS. The molecular basis for cyclopiazonic 
acid inhibition of the sarcoplasmic reticulum calcium pump. J Biol Chem 
282: 9748-9757, 2007 
Mullis KB, Faloona FH. Specific synthesis of DNA in vitro via a 
polymerase-catalyzed chain reaction. Methods Enzymol 155: 335-350, 
1987 
N´Gouemo P, Morad M. Voltage-gated calcium channels in adult rat 
inferior colliculus neurons. Neuroscience 120: 815-826, 2003 
Nakao K, Takahashi T, Utsunomiya J, Owyang C. Extrinsic neural 
control of oxide synthase expression in the myenteric plexus of rat jejunum. 
J Physiol 507: 549-560, 1998 
Nemeth PR, Zafirov D, Wood JD. Forskolin mimics slow synaptic 
excitation in myenteric neurons. Eur J Pharmacol 101: 303-304, 1984  
Newton CR, Graham A. PCR. Intoduction to scientific techniques. 2d. 
ed. BIOS scientific publishers Ltd.,Oxford, 1997 
Nishi S, North RA. Intracellular recording from the myenteric plexus of the 
guinea-pig ileum. J Physiol 231: 471-491, 1973 
Noll S, Schaub-Kuhnen S. Praxis der Immunhistochemie. 1. ed. Urban 
und Fischer, München, 2000 
Nonidez JF. Afferent nerve endings in the ganglia of the intermuscular 
plexus of the dog’s esophagus. J Comp Neurol 85: 177-185, 1946 
 108
Nooney JM, Lambert RC, Feltz A. Identifying neuronal non-L Ca2+ 
channels; more than stamp collecting? Trends Pharmacol Sci 18: 363-371, 
1997 
North RA. Electrophysiology of the enteric nervous system. Neuroscience 
7: 315-325, 1982 
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the 
biological activity of endothelium-derived relaxing factor. Nature 327: 524-
526, 1987 
Palmer RM, Moncada S. A novel citruline-forming enzyme implicated in 
the formation of nitric oxide by vascular endothelial cells. Biochem Biophys 
Res Cummun 158: 348-352, 1989 
Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, 
Grisham MB. Serial review: Reactive oxygen and nitrogen in 
inflammation. Free Rad Biol Med 33: 311-322, 2002 
Pelzer D, Pelzer S, McDonald TF. Properties and regulation of calcium 
channels in muscle cells. Rev Physiol Biochem Pharmacol 114: 108-206, 
1990 
Petzold GC, Scheibe F, Braun JS, Freyer D, Priller J, Dirnagl U, Dreier 
JP. Nitric oxide modulates calcium entry through P/Q-type calcium 
channels and N-methyl-D-aspartate receptors in rat cortical neurons. Brain 
Research 1063: 9–14, 2005 
Phillips RJ, Baronowsky EA, Powley TL. Afferent innervation of 
gastrointestinal tract smooth muscle by the hepatic branch of the vagus. J 
Comp Neurol 384: 248-270, 1997 
Pilipenko VI. Contributions to the functional morphology of the peripheral 
nervous system. Part ΙΙ. Functional nature of Dogiel’s type ΙΙ cells. Bull Exp 
Biol Med 41: 449-452, 1956 
Powley TL, Holst MC, Boyd DB, Kelly JB. Three dimensional 
reconstructions of autonomic projections to the gastrointestinal tract. 
Microsc Res Technol 29: 297-309, 1994 
Powley TL, Phillips RJ. Musing on the wanderer. What’s new in our 
understanding of vago-vagal reflexes? I. Morphology and topogaphy of 
vagal afferents innervating the GI tract. Am J Physiol Gastrointest Liver 
Physiol 283: G1217-G1225, 2002 
Powley TL. Vagal input to the enteric nervous system. Gut 47: 30-32, 2000 
Prechtl JC, Powley TL. The fibers composition of the abdominal vagus of 
the rat. Anat Embryol 181: 101-115, 1990 
 109
Publicover NG, Hammond EM, Sanders KM. Amplification of nitric oxide 
signaling by interstitial cells isolated from canine colon. Proc Natl Acad Sci 
USA 90: 2087–2091, 1993 
Quintana E, Hernández C, Álvarez-Barrientos A, Esplugues JV, 
Barrachina MD. Synthesis of nitric oxide in postganglionic myenteric 
neurons during endotoxemia: implications for gastric motor function in 
rats. FASEB J 18: 531-533, 2004 
Regan LJ. Voltage-dependent calcium currents in Purkinje cells from rat 
cerebellar vermis. J Neurosci 11: 2259–2269, 1991 
Rehn M, Hübschle T, Diener M. TNF-α hyperpolarises membrane 
potential and potentiates the response to nicotinic receptor stimulation in 
cultured rat myenteric neurons. Acta Physiol Scand 181: 13-22, 2004 
Ritter RC, Brenner L, Yox DP. Participation of vagal sensory neurons in 
putative satiety signals from upper gastrointestinal tract. In: Ritter S, Ritter 
RC, Barnes CD(eds) Neuroanatomy and physiology of abdominal vagal 
afferents. CRC Press, Boca Raton, Ann Arbor, Boston, pp 221-248, 1992 
Rodrigo J, Hernàndez CJ, Vidal MA, Pedrosa JA. Vegetative innervation 
of the esophagus. II Intraganglionic laminar endings. Acta Anat 92: 79-100, 
1975 
Roman C, Gonella J. Extrinsic control of digestive motility. In L.R. 
Johnson, J. Christensen, M.J. Jackson, E.D. Jacobson and J.H. 
Walsh(eds): Physiology of the Gastrointestinal Tract, Vol. 1. New York: 
Raven Press pp 507-553, 1987 
Roony TA, Joseph SK, Queen C, Thomas AP. Cyclic GMP induces 
oscillatory calcium signals in rat hepatocytes. J Biol Chem 271: 19817-
19825, 1996 
Rühl A, Collins SM. Role of nitric oxide in norepinephrine release from 
myenteric plexus in vitro and in Trichinella spiralis-infected rats. 
Neurogastroenterol Motil 9: 33–39, 1997 
Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim 
N. Enzymatic amplification of beta-globin genomic sequences and 
restriction site analysis for diagnosis of sickle cell anemia. Science 230: 
1350-1354, 1985 
Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory 
manual 2nd. Ed. New York:Cold Spring Harbor Laboratory Press, 1989 
 110
Sanders KM, Ward SM. Nitric oxide as a mediator of nonadrenergic 
noncholinergic neurotransmission. Am J Physiol Gastrointest Liver Physiol 
262: G379-G392, 1992  
Sanders KM. A case for interstitial cells of Cajal as pacemakers and 
mediators of neurotransmission in the gastrointestinal tract. 
Gastroenterology 111:492-515,1996 
Sanguinetti MC, Kass RS. Voltage-dependent block of calcium channel 
current in calf purkinje fiber by dihydropyridine calcium channel 
antagonists. Circ Res 55: 336-348, 1984 
Santiago AR, Carvalho CM, Carvalho AP, Ambrósio AF. Differential 
Contribution of L-, N-, and P/Q-type calcium channels to [Ca2+]i changes 
evoked by kainate in hippocampal neurons. Neurochem Res 33: 1501-
1508, 2008 
Schäfer KH, Saffrey MJ, Brunstock G, Mestres-Ventura P. A new 
method for the isolation of myenteric plexus from the newborn rat 
gastrointestinal tract. Brain Res Protoc 1: 109-113, 1997 
Schäufele N, Diener M. Pharmacological characterisation of voltage-
dependent Ca2+ channels in isolated ganglia from the myenteric plexus. Life 
Scie 77: 2489–2499, 2005 
Schemann M, Grundy D. Electrophysiological identification of vagally 
innervated enteric neurons in guinea pig stomach. Am J Physiol 263: G709-
G718, 1992 
Schemann M, Wood JD. Synaptic behavior of myenteric neurons in the 
gastric corpus of the guinea-pig. J Physiol 417: 519-535, 1989 
Schricker K, Pötzl B, Hamann M, Kurtz A. Coordinate changes of 
renin and brain-type nitric-oxide-synthase (b-NOS) mRNA levels in rat 
kidneys. Pflügers Arch Eur J Physiol 432: 394-400, 1996 
Schultheiss G, Seip G, Kocks SL, Diener M. Ca2+-dependent and Ca2+-
independent Cl- secretion stimulated by the nitric oxide donor, GEA 3162, 
in rat colonic epithelium. Eur J Pharmacol 444: 21-30, 2002 
Sharp PA, Suqden B, Sambrook J. Detection of two restriction 
endonuclease activities in haemophilus parainfluenza using analytical 
agarose-ethidium bromide electophoresis. Biochemistry 12: 3055-3063, 
1973 
Sher E, Biancardi E, Passafaro M, Clementi F. Physiopathology of 
neuronal voltage-operated calcium channels. FASEB J 5: 2677-2683, 1991 
 111
Simpson PB, Challis RAJ, Nahorski SR. Neuronal Ca2+ stores: activation 
and function. Trends Neurosci 18: 299-306, 1995 
Sitmo M, Rehn M, Diener M. Stimulation of voltage-dependent Ca2+ 
channels by NO at rat myenteric neurons. Am J Physiol Gastrointest 
Liver Physiol 293: G886-G893, 2007 
Smith GP, Rauhofer EA, Gibbs J. CCK-8 inhibits meal size in rats that 
have only the hepatic-dudenal vagal branch intact 1995. Benjamin 
Franklin/Lafayette Symphaguik (abstract). Appetite 24: 93, 1994 
Smith TK, Reed JB, Sanders KM. Electrical pacemakers of canine 
proximal colon are functionally innervated by inhibitory motor neuronsn. Am 
J Physiol 256: C466-C477, 1989 
Stolovitzky G, Cecchi G. Efficiency of DNA replication in the polymerase 
chain reaction. Proc Nat Acad Sci USA 93: 12947-12952, 1996 
Surprenant A, North RA. Mechanism of synaptic inhibition by 
noradrenaline acting at alpha 2-adrenoceptors. Proc R Soc Lond 234: 85-
114, 1988 
Takahashi T. Pathophysiological significance of neuronal nitric oxide 
synthase in the gastrointestinal tract. Gastroenterology 38: 421-430, 
2003 
Tamura K, Schemann M, Wood JD. Actions of nitric oxide-generating 
sodium nitroprusside in myenteric plexus of guinea pig small intestine. Am 
J Physiol 265: G887–G893, 1993 
Thornbury KD, Ward SM, Dalziel HH, Carl A, Westfall DP, Sanders KM. 
Nitric oxide and nitrosocysteine mimic nonadrenergic, noncholinergic 
hyperpolarization in canine proximal colon. Am J Physiol Gastrointest Liver 
Physiol 261: G553-G557, 1991 
Thuneberg L. Interstitial cells of Cajal: Intestinal pacemaker cells? Adv 
Anat Embryol Cell Biol 71: 1-130, 1982 
Triggle DJ. Calcium channel antagonists: Clinical uses: Past, present and 
future. Biochem Pharmacol 74: 1-9, 2007 
Tringham EW, Dupere JRB, Payne CE, Usowicz MM. Protease treatment 
of cerebellar Purkinje cells renders ω-Agatoxin IVA-sensitive Ca2+ channels 
insensitive to inhibition by ω-conotoxin GVIA. J Pharmacol Exp Therap 324: 
806-808, 2008 
 112
Tsien RY, Rink TJ, Poenie M. Measurement of cytosolic free Ca+2 in 
individual small cells using fluorescence microscopy with dual excitation 
wavelengths. Cell Calcium 6: 145-157, 1985  
Tsien RY. A non-disruptive technique for loading calcium buffers and 
indicators into cells. Nature 290: 527-528, 1981 
Tsien RY. Fluorescent probes of cell signaling. Ann Rev Neurosci 12: 227-
253, 1989 
Tsien RY. New calcium indicators and buffers with high selectivity against 
magnesium and protons: Design, synthesis, and properties of prototype 
structures. Biochemistry 19: 2396-2404, 1980 
Valentine JF, Tannahill CL, Stevenot SA, Sallustio JE, Nick HS, 
Eaker EY. Colitis and interleukin 1β up-regulation inducible nitric oxide 
synthase and superoxide dismutase in rat myenteric neurons. 
Gastroenterology 111: 56-64, 1996 
Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, van Goor H, 
Jansen PLM, Mashimo H, Collins SM. Relative contributions of NOS 
isoforms during experimental colitis: endothelial-derived NOS maintains 
mucosal integrity. Am J Physiol Gastrointest Liver Physiol 287: G865-
G874, 2004 
Walls EK, Wang FB, Holst M-C, Phillips RJ, Powley TL. Suppression of 
meal size by intestinal nutrients is eliminated by celiac vagal 
deafferentation. Am J Physiol 269: R1410-R1419, 1995 
Wang FB, Powley TL. Topographic inventories of vagal afferents in the 
gastrointestinal muscle. J Comp Neurol 421: 302-324, 2000 
Wang FB, Powley TL. Toxonomy of vagal afferent projections to the 
gastrointestinal tract. Soc Neurosci Abstr 20: 1375, 1994 
Wang Y, Marsden PA. Nitric oxide synthase: gene structure and 
regulation. Adv Pharmacol 43: 71-90, 1995 
Wang ZQ, Watanabe Y, Toki A, kohno S, Hasegawa S, Hamazaki M. 
Involvement of endogenous nitric oxide and c-kit-expressing cells in chronic 
intestinal pseudo-obstruction. J Pediatr Surg 35: 539-544, 2000 
Ward SM. Interstitial cells of Cajal in enteric neurotransmission. Gut 47: 40-
43, 2000 
Ward SM, Burns AJ, Torihashi S, Sanders KM. Mutation of the proto-
oncogene c-kit blocks development of interstitial cells and electrical 
rhythmicity in murine intestine. J Physiol 480: 91-97, 1994 
 113
Wiklund CU, Olgart C, Wiklund NP, Gustafsson LE. Modulation of 
cholinergic and substance P-like neurotransmission by nitric oxide in the 
guinea-pig ileum. Br J Pharmacol 110: 833-839, 1993 
Williams RM, Berthoud HR, Stead RH. Vagal afferent nerve fibers contact 
mast cells in rat small intestinal mucosa. Neuroimmunomodulation 4: 266-
270, 1997 
Wood JD, Mayer CJ. Serotonergic activation of tonic-type enteric neurons 
in guinea-pig small bowel. J Neurophysiol 42: 582-593, 1979  
Wood JD. Enteric neuroimmunophysiology and pathophysiology. 
Gastroenterology 127: 635–657, 2004 
Wood JD. Enteric neurophysiology. Am J Physiol 10: G585-G598, 1984 
Wood JD. Physiology of the enteric nervous system. In L.R. Johnson (ed): 
Physiology of the gastrointestinal Tract.2nd Ed. New York: Raven Press, pp 
67-109, 1987 
Wood JD. Physiology of the enteric nervous system. In: Physiology of the 
Gastrointestinal Tract, Vol. 1, 3rd Edition. Hrsg.: Johnson LR, Raven Press, 
New York 423-482, 1994 
Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, 
Ding A, Troso T, Nathan C. Cloning and characterization of inducible 
nitric oxide synthase from mouse macrophages. Science 256: 225-228, 
1992  
Yoshimura N, Seki S, de Groat WC. Nitric oxide modulates Ca2+ channels 
in dorsal root ganglion neurons innervating rat urinary bladder. J 
Neurophysiol 86: 304–311, 2001 
Young HM, McConalogue K, Furness JB, DE Vente J. Nitric oxide 
targets in the guinea-pig intestine identified by induction of cyclic GMP 
immunoreactivity. Neuroscience 55: 583-596, 1993 
Yuan SY, Bornstein JC, Furness JB. Pharmacological evidence that 
nitric oxide may be a retrograde messenger in the enteric nervous 
system. Brit J Pharmacol 114: 428-432, 1995 
Zaitsev AV, Povysheva NV, Lewis DA, Krimer LS. P/Q-Type, but not 
N-type calcium channels mediate GABA release from fast-spiking 
interneurons to pyramidal cells in rat prefrontal cortex. J Neurophysiol 
97: 3567-3573, 2007 
 114
8. Acknowledgments 
 
I would like to express my sincere gratitude to my supervisor Prof. 
Dr. Martin Diener for his excellent guidance and for his great 
support, patience and enthusiasm during completion this study. 
 
I specially acknowledge Dr. Matthias Rehn for his expert and 
practical help in data analysis. 
 
I am grateful to Brigitta Brück for friendly help in PCR experiments. 
 
Furthermore I wish to thank Anne Siefjediers, Eva-Maria Haas, 
Alice Metternich, Michael Haas, Silke Handstein, Daniela Hild, 
Karl-Hermann Maurer, Britta Henning, Bärbel Schmidt and all 
people in the Institute for Veterinary Physiology for various 
supports. 
 
Surely my words will not encompass my thank and gratitude to my 
family for hearing, understanding, encouragment and most of all 
love even when they were so far away in moments I saw no light to 
go the way to the end. 
 115
9. Erklärung 
Ich erkläre: Ich habe die vorgelegte Dissertation selbständig und ohne 
unerlaubte fremde Hilfe und nur mit den Hilfen angefertigt, die ich in der 
Dissertation angegeben habe. Alle Textstellen, die wörtlich oder 
sinngemäß aus veröffentlichten oder nicht veröffentlichten Schriften 
entnommen sind, und alle Angaben, die auf mündlichen Auskünften 
beruhen, sind als solche kenntlich gemacht. Bei den von mir 
durchgeführten und in der Dissertation erwähnten Untersuchungen 
habe ich die Grundsätze guter wissenschaftlicher Praxis, wie sie in der 
„Satzung der Justus-Liebig-Universität Gießen zur Sicherung guter 
wissenschaftlicher Praxis“ niedergelegt sind, eingehalten. 
 
 
M
A
B
R
U
K
A
 
S
I
T
M
O
 
 
 
 
 
 
 
 
S
T
I
M
U
L
A
T
I
O
N
 
O
F
 
V
D
C
C
s
 
B
Y
 
N
O
 
A
T
 
M
Y
E
N
T
E
R
I
C
 
G
A
N
G
L
I
A
MABRUKA SITMO
INAUGURAL-DISSERTATION
zur Erlangung des Grades eines 
Dr. med. vet. 
beim Fachbereich Veterinärmedizin
der Justus-Liebig-Universität Gießen
 
VVB
9 7 8 3 8 3 5 9 5 3 8 6 4
ISBN 3-8359-5386-9VVB LAUFERSWEILER VERLAG
STAUFENBERGRING 15
D-35396 GIESSEN
Tel: 0641-5599888 Fax: -5599890
redaktion@doktorverlag.de
www.doktorverlag.de
VVB LAUFERSWEILER VERLAG
édition scientifique
VVB LAUFERSWEILER VERLAG
édition scientifique
 ﻮﻤﺘﻴﺳ ﺪﻤﺣ ﺢﻟﺎﺻ ﺔﻛﻭﺮﺒﻣ
Stimulation of voltage-dependent Ca  channels 
by NO at rat myenteric ganglia
2+
